| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 CASP8AP2 NRIP1 ATG16L1 TRAF2 SORBS2 SASH1 ANK3 VGLL2 ITSN1 SH2D3C RICTOR RB1CC1 ZZEF1 TRRAP JMJD1C SHANK3 HIPK3 KAT7 BRCA1 YAP1 RPTOR RLIM TJP2 AKAP13 TOX2 MED13 RAB11FIP3 | 1.24e-05 | 1356 | 171 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SHANK1 CASP8AP2 NRIP1 ATG16L1 TRAF2 SORBS2 ANK3 VGLL2 SH2D3C RB1CC1 ZZEF1 TRRAP JMJD1C SHANK3 HIPK3 KAT7 BRCA1 YAP1 RPTOR RLIM TJP2 AKAP13 TOX2 MED13 RAB11FIP3 | 1.89e-05 | 1160 | 171 | 25 | GO:0030674 |
| GeneOntologyBiologicalProcess | organelle assembly | ATG4A ATMIN ATG16L1 PDGFRB TMEM175 OBSCN BBS2 RB1CC1 CCDC57 SHANK3 TTBK2 MYLK3 BRCA1 CELSR2 MTOR YAP1 SNX7 TBC1D1 CC2D2A CFAP74 AKAP13 WDR44 MYBPC3 RAB11FIP3 | 2.63e-05 | 1138 | 172 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | microautophagy | 4.36e-05 | 24 | 172 | 4 | GO:0016237 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | STK32B SH2D3C RICTOR MAST2 HIPK3 TGFBR1 TTBK2 MTOR RPTOR AKT2 TNKS1BP1 | 5.60e-05 | 307 | 172 | 11 | GO:0018105 |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | PDGFRB STK32B SH2D3C RICTOR MAST2 GRM5 ZZEF1 FSCB HIPK3 TGFBR1 KAT7 TTBK2 PTPN4 MTOR NDUFAF7 RPTOR KMT2A AKT2 TNKS1BP1 TOPORS SNTA1 | 6.61e-05 | 976 | 172 | 21 | GO:0018193 |
| GeneOntologyBiologicalProcess | learning | 7.47e-05 | 212 | 172 | 9 | GO:0007612 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | STK32B SH2D3C RICTOR MAST2 HIPK3 TGFBR1 TTBK2 MTOR RPTOR AKT2 TNKS1BP1 | 7.89e-05 | 319 | 172 | 11 | GO:0018209 |
| GeneOntologyCellularComponent | TOR complex | 1.20e-04 | 12 | 175 | 3 | GO:0038201 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SHANK1 ATG16L1 PCLO ITSN1 CNKSR2 BCAN PDE10A GRM4 GRM5 SHANK3 SEMA3A CBLN4 NEO1 P2RY4 MTOR ACAN LRRC7 CPEB1 | 1.79e-04 | 817 | 175 | 18 | GO:0098978 |
| HumanPheno | Abnormality of globe location or size | ERCC5 MAN2B1 NUP107 FOXP2 PDGFRB SMCHD1 PCLO PHF6 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR YAP1 HECW2 ASXL3 BUB1 RLIM PAH KMT2A CC2D2A NHS MACF1 LRPAP1 CHD6 HERC1 TOPORS MED13 TBCD | 1.23e-06 | 1246 | 68 | 35 | HP:0000489 |
| HumanPheno | Abnormal palate morphology | DMXL2 ERCC5 NUP107 FOXP2 SMCHD1 COBLL1 PCLO PHF6 BBS2 MECOM RREB1 FANCM LARS2 TRRAP JMJD1C SHANK3 FANCA SEMA3A TGFBR1 ZNF469 BRCA1 BRCA2 YAP1 HECW2 ASXL3 BUB1 RLIM PAH KMT2A CC2D2A CHD6 HERC2 HERC1 TOPORS | 1.70e-06 | 1202 | 68 | 34 | HP:0000174 |
| HumanPheno | Tall stature | MAN2B1 ANK3 PDGFRB AGGF1 LARS2 SHANK3 TGFBR1 ZNF469 BRCA2 MTOR ASXL3 AKT2 HERC1 | 6.22e-06 | 225 | 68 | 13 | HP:0000098 |
| HumanPheno | Choanal atresia or stenosis | 8.99e-06 | 134 | 68 | 10 | HP:0000416 | |
| HumanPheno | Abnormal choanae morphology | 8.99e-06 | 134 | 68 | 10 | HP:0000415 | |
| HumanPheno | Prominent nasal bridge | PDGFRB BBS2 RREB1 TRRAP JMJD1C BRCA1 ASXL3 RLIM CC2D2A NHS HERC1 TOPORS MED13 | 1.20e-05 | 239 | 68 | 13 | HP:0000426 |
| HumanPheno | Abnormality of globe size | ERCC5 PDGFRB SMCHD1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 YAP1 BUB1 CC2D2A NHS LRPAP1 CHD6 | 1.37e-05 | 319 | 68 | 15 | HP:0100887 |
| HumanPheno | Disproportionate tall stature | 1.41e-05 | 41 | 68 | 6 | HP:0001519 | |
| HumanPheno | Cleft palate | DMXL2 ERCC5 NUP107 FOXP2 SMCHD1 COBLL1 MECOM RREB1 FANCM LARS2 TRRAP JMJD1C FANCA SEMA3A TGFBR1 ZNF469 BRCA1 BRCA2 YAP1 BUB1 CC2D2A TOPORS | 1.62e-05 | 643 | 68 | 22 | HP:0000175 |
| HumanPheno | Orofacial cleft | DMXL2 ERCC5 NUP107 FOXP2 SMCHD1 COBLL1 PHF6 MECOM RREB1 FANCM LARS2 TRRAP JMJD1C FANCA SEMA3A TGFBR1 ZNF469 BRCA1 BRCA2 YAP1 BUB1 CC2D2A TOPORS | 1.63e-05 | 694 | 68 | 23 | HP:0000202 |
| HumanPheno | Craniofacial cleft | DMXL2 ERCC5 NUP107 FOXP2 SMCHD1 COBLL1 PHF6 MECOM RREB1 FANCM LARS2 TRRAP JMJD1C FANCA SEMA3A TGFBR1 ZNF469 BRCA1 BRCA2 YAP1 BUB1 CC2D2A TOPORS | 1.63e-05 | 694 | 68 | 23 | HP:5201015 |
| HumanPheno | Small eyes | ERCC5 PDGFRB SMCHD1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 YAP1 BUB1 CC2D2A NHS CHD6 | 1.70e-05 | 285 | 68 | 14 | HP:0001143 |
| HumanPheno | Microphthalmia | ERCC5 PDGFRB SMCHD1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 YAP1 BUB1 CC2D2A NHS CHD6 | 1.70e-05 | 285 | 68 | 14 | HP:0000568 |
| HumanPheno | Abnormal hard palate morphology | DMXL2 ERCC5 NUP107 FOXP2 SMCHD1 COBLL1 MECOM RREB1 FANCM LARS2 TRRAP JMJD1C FANCA SEMA3A TGFBR1 ZNF469 BRCA1 BRCA2 YAP1 BUB1 CC2D2A TOPORS | 1.79e-05 | 647 | 68 | 22 | HP:0100737 |
| HumanPheno | Abnormal eyelid morphology | DMXL2 ERCC5 MAN2B1 FOXP2 PDGFRB SMCHD1 PCLO PHF6 BBS2 CNKSR2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 ZNF469 BRCA1 BRCA2 MTOR HECW2 ASXL3 BUB1 RLIM PAH KMT2A MACF1 CHD6 HERC2 HERC1 TOPORS MED13 TBCD SPINK5 | 2.42e-05 | 1408 | 68 | 35 | HP:0000492 |
| HumanPheno | Hypertelorism | MAN2B1 NUP107 FOXP2 PDGFRB SMCHD1 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR ASXL3 RLIM KMT2A CC2D2A MACF1 HERC1 TOPORS MED13 TBCD | 3.20e-05 | 830 | 68 | 25 | HP:0000316 |
| HumanPheno | Abnormal finger phalanx morphology | DMXL2 ERCC5 NUP107 PDGFRB PHF6 BBS2 MECOM RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 MTOR ACAN ASXL3 RLIM PAH KMT2A CC2D2A NHS TOPORS | 4.47e-05 | 738 | 68 | 23 | HP:0005918 |
| HumanPheno | Abnormal conjugate eye movement | SPATA7 DMXL2 ERCC5 MAN2B1 FOXP2 BBS2 RREB1 FANCM LARS2 JMJD1C SHANK3 GPR179 FANCA TGFBR1 BRCA1 BRCA2 ATXN1 MTOR YAP1 HECW2 ASXL3 PAH KMT2A CC2D2A NHS MACF1 CHD6 HERC2 TOPORS MED13 TBCD | 4.75e-05 | 1198 | 68 | 31 | HP:0000549 |
| HumanPheno | Abnormal hand morphology | DMXL2 NUP107 FOXP2 PDGFRB PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR ACAN ASXL3 BUB1 PAH KMT2A CC2D2A NHS CHD6 MMP1 HERC2 HERC1 TOPORS | 5.12e-05 | 1082 | 68 | 29 | HP:0005922 |
| HumanPheno | Strabismus | SPATA7 DMXL2 ERCC5 MAN2B1 FOXP2 BBS2 RREB1 FANCM LARS2 JMJD1C SHANK3 GPR179 FANCA TGFBR1 BRCA1 BRCA2 MTOR YAP1 HECW2 ASXL3 PAH KMT2A CC2D2A NHS MACF1 CHD6 HERC2 TOPORS MED13 TBCD | 6.91e-05 | 1159 | 68 | 30 | HP:0000486 |
| HumanPheno | Hypoplasia of the olfactory bulb | 7.67e-05 | 7 | 68 | 3 | HP:0040326 | |
| HumanPheno | Sideroblastic anemia | 8.70e-05 | 35 | 68 | 5 | HP:0001924 | |
| HumanPheno | Abnormal hair morphology | DMXL2 ERCC5 MAN2B1 SASH1 NUP107 FOXP2 PDGFRB SMCHD1 PHF6 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA ZNF469 BRCA1 BRCA2 MTOR HECW2 ASXL3 RLIM PAH KMT2A CC2D2A CHD6 MMP1 HERC2 HERC1 TOPORS MED13 TBCD SPINK5 | 8.75e-05 | 1424 | 68 | 34 | HP:0001595 |
| HumanPheno | Abnormality of the jaws | ERCC5 MAN2B1 NUP107 FOXP2 PDGFRB COBLL1 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 ACAN ASXL3 SVIL BUB1 RLIM PAH KMT2A CC2D2A NHS CHD6 HERC2 HERC1 TOPORS TBCD | 9.05e-05 | 1175 | 68 | 30 | HP:0000209 |
| HumanPheno | Abnormal jaw morphology | ERCC5 MAN2B1 NUP107 FOXP2 PDGFRB COBLL1 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 ACAN ASXL3 SVIL BUB1 RLIM PAH KMT2A CC2D2A NHS CHD6 HERC2 HERC1 TOPORS TBCD | 9.20e-05 | 1176 | 68 | 30 | HP:0030791 |
| HumanPheno | Abnormality of globe location | MAN2B1 NUP107 FOXP2 PDGFRB SMCHD1 PCLO PHF6 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR HECW2 ASXL3 RLIM PAH KMT2A CC2D2A MACF1 HERC1 TOPORS MED13 TBCD | 1.03e-04 | 1122 | 68 | 29 | HP:0100886 |
| HumanPheno | Hand polydactyly | NUP107 BBS2 RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 PAH CC2D2A TOPORS | 1.09e-04 | 254 | 68 | 12 | HP:0001161 |
| HumanPheno | Duplication of phalanx of hand | NUP107 BBS2 RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 PAH CC2D2A TOPORS | 1.22e-04 | 257 | 68 | 12 | HP:0009997 |
| HumanPheno | Duplication of hand bones | NUP107 BBS2 RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 PAH CC2D2A TOPORS | 1.27e-04 | 258 | 68 | 12 | HP:0004275 |
| HumanPheno | Duplication of bones involving the upper extremities | NUP107 BBS2 RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 PAH CC2D2A TOPORS | 1.27e-04 | 258 | 68 | 12 | HP:0009142 |
| HumanPheno | Abnormal finger morphology | DMXL2 ERCC5 NUP107 FOXP2 PDGFRB PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 ZNF469 BRCA1 BRCA2 MTOR ACAN ASXL3 SVIL BUB1 RLIM PAH KMT2A CC2D2A NHS CFAP74 CHD6 HERC2 HERC1 TOPORS | 1.29e-04 | 1385 | 68 | 33 | HP:0001167 |
| HumanPheno | Hypogonadism | SPATA7 DMXL2 ERCC5 NUP107 SMCHD1 PHF6 LGR4 BBS2 FANCM FANCA SEMA3A BRCA1 BRCA2 CC2D2A HERC2 TOPORS | 1.54e-04 | 439 | 68 | 16 | HP:0000135 |
| HumanPheno | Gracile long bones | 1.60e-04 | 89 | 68 | 7 | HP:0003061 | |
| HumanPheno | Slender long bone | 1.60e-04 | 89 | 68 | 7 | HP:0003100 | |
| HumanPheno | Sloping forehead | 1.66e-04 | 188 | 68 | 10 | HP:0000340 | |
| HumanPheno | Hypopigmented skin patches | 1.91e-04 | 122 | 68 | 8 | HP:0001053 | |
| HumanPheno | Choanal atresia | 2.02e-04 | 123 | 68 | 8 | HP:0000453 | |
| HumanPheno | Pyridoxine-responsive sideroblastic anemia | 2.12e-04 | 23 | 68 | 4 | HP:0005522 | |
| HumanPheno | Slender build | 2.19e-04 | 66 | 68 | 6 | HP:0001533 | |
| HumanPheno | Abnormality of the palpebral fissures | DMXL2 FOXP2 PDGFRB PCLO PHF6 BBS2 CNKSR2 RREB1 FANCM TRRAP JMJD1C FANCA TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A HERC2 HERC1 MED13 TBCD | 2.50e-04 | 880 | 68 | 24 | HP:0008050 |
| HumanPheno | Abnormal mandible morphology | ERCC5 MAN2B1 NUP107 PDGFRB BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 ACAN ASXL3 SVIL BUB1 RLIM PAH KMT2A CC2D2A NHS CHD6 HERC2 HERC1 TOPORS TBCD | 2.60e-04 | 1118 | 68 | 28 | HP:0000277 |
| HumanPheno | Abnormality of hair pigmentation | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA ZNF469 BRCA1 BRCA2 MTOR PAH HERC2 | 2.74e-04 | 280 | 68 | 12 | HP:0009887 |
| HumanPheno | patches | 2.81e-04 | 129 | 68 | 8 | HP:0200033 | |
| HumanPheno | Epicanthus | DMXL2 MAN2B1 FOXP2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA ZNF469 BRCA1 BRCA2 HECW2 ASXL3 BUB1 PAH KMT2A MACF1 TOPORS | 2.87e-04 | 614 | 68 | 19 | HP:0000286 |
| HumanPheno | Absent testis | 2.97e-04 | 25 | 68 | 4 | HP:0010469 | |
| HumanPheno | Abnormality of the bladder | NRIP1 MAN2B1 FOXP2 PDGFRB BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA BRCA1 BRCA2 ATXN1 PAH CC2D2A MACF1 MMP1 TBCD | 3.33e-04 | 621 | 68 | 19 | HP:0000014 |
| HumanPheno | Hypoplastic facial bones | MAN2B1 FOXP2 PDGFRB COBLL1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 3.49e-04 | 331 | 68 | 13 | HP:0002692 |
| HumanPheno | Aplasia/Hypoplasia of facial bones | MAN2B1 FOXP2 PDGFRB COBLL1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 3.59e-04 | 332 | 68 | 13 | HP:0034261 |
| HumanPheno | Autistic behavior | DMXL2 ANK3 FOXP2 BBS2 IREB2 CNKSR2 RREB1 TRRAP JMJD1C SHANK3 MTOR HECW2 ASXL3 RLIM PAH KMT2A CC2D2A NHS HERC2 MED13 | 3.61e-04 | 678 | 68 | 20 | HP:0000729 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | DMXL2 ERCC5 NUP107 FOXP2 PDGFRB SMCHD1 COBLL1 PHF6 MECOM RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR ACAN ASXL3 BUB1 RLIM PAH KMT2A CC2D2A NHS CHD6 HERC2 TOPORS TBCD | 4.55e-04 | 1343 | 68 | 31 | HP:0009115 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | ERCC5 NUP107 FOXP2 PDGFRB SMCHD1 COBLL1 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 ASXL3 BUB1 RLIM PAH KMT2A CC2D2A CHD6 TOPORS TBCD | 4.58e-04 | 915 | 68 | 24 | HP:0009116 |
| HumanPheno | Aplasia/Hypoplasia of the uvula | 4.67e-04 | 28 | 68 | 4 | HP:0010293 | |
| HumanPheno | Diagnostic behavioral phenotype | DMXL2 ANK3 FOXP2 PDGFRB BBS2 IREB2 CNKSR2 RREB1 TRRAP JMJD1C SHANK3 MTOR HECW2 ASXL3 RLIM PAH KMT2A CC2D2A NHS HERC2 MED13 | 4.76e-04 | 747 | 68 | 21 | HP:0025783 |
| HumanPheno | Abnormal facial shape | MAN2B1 NUP107 FOXP2 PDGFRB COBLL1 PHF6 BBS2 RREB1 FANCM JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 MTOR ACAN ASXL3 BUB1 RLIM PAH KMT2A CC2D2A NHS MACF1 AKT2 CHD6 HERC1 TOPORS | 4.87e-04 | 1221 | 68 | 29 | HP:0001999 |
| HumanPheno | Duodenal stenosis | 5.37e-04 | 29 | 68 | 4 | HP:0100867 | |
| HumanPheno | Small intestinal stenosis | 5.37e-04 | 29 | 68 | 4 | HP:0012848 | |
| HumanPheno | Bicornuate uterus | 5.84e-04 | 52 | 68 | 5 | HP:0000813 | |
| HumanPheno | Abnormal pinna morphology | ERCC5 MAN2B1 NUP107 FOXP2 SMCHD1 PCLO PHF6 BBS2 IREB2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 HECW2 ACAN ASXL3 BUB1 PAH KMT2A CC2D2A NHS MACF1 HERC1 TOPORS TBCD | 6.02e-04 | 1299 | 68 | 30 | HP:0000377 |
| HumanPheno | Clubbing of toes | 6.13e-04 | 30 | 68 | 4 | HP:0100760 | |
| HumanPheno | Aplasia/Hypoplasia of the testes | 6.13e-04 | 221 | 68 | 10 | HP:0010468 | |
| HumanPheno | Meckel diverticulum | 6.97e-04 | 31 | 68 | 4 | HP:0002245 | |
| HumanPheno | Facial asymmetry | 7.42e-04 | 149 | 68 | 8 | HP:0000324 | |
| HumanPheno | Abnormal enteric ganglion morphology | 7.75e-04 | 150 | 68 | 8 | HP:0004362 | |
| HumanPheno | Aganglionic megacolon | 7.75e-04 | 150 | 68 | 8 | HP:0002251 | |
| HumanPheno | Megacolon | 7.75e-04 | 150 | 68 | 8 | HP:6000852 | |
| HumanPheno | Abnormal testis morphology | SPATA7 DMXL2 ERCC5 MAN2B1 SMCHD1 PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C FANCA SEMA3A TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A CC2D2A CHD6 HERC2 TOPORS TBCD | 7.80e-04 | 1129 | 68 | 27 | HP:0000035 |
| HumanPheno | Abnormal autonomic nervous system morphology | 8.10e-04 | 151 | 68 | 8 | HP:0012331 | |
| HumanPheno | Abnormal enteric nervous system morphology | 8.10e-04 | 151 | 68 | 8 | HP:0025028 | |
| HumanPheno | Non-obstructive azoospermia | SPATA7 DMXL2 ERCC5 MAN2B1 SMCHD1 PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C FANCA SEMA3A TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A CC2D2A CHD6 HERC2 TOPORS TBCD | 8.14e-04 | 1132 | 68 | 27 | HP:0011961 |
| HumanPheno | Abnormal toe morphology | DMXL2 ERCC5 NUP107 PHF6 BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 ZNF469 BRCA1 BRCA2 ACAN ASXL3 SVIL KMT2A CC2D2A HERC2 HERC1 TOPORS | 8.31e-04 | 893 | 68 | 23 | HP:0001780 |
| HumanPheno | Hypopigmentation of hair | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 MTOR PAH HERC2 | 9.34e-04 | 276 | 68 | 11 | HP:0005599 |
| HumanPheno | Ocular albinism | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 MTOR PAH HERC2 | 9.34e-04 | 276 | 68 | 11 | HP:0001107 |
| HumanPheno | Generalized hypopigmentation | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 MTOR PAH HERC2 | 9.34e-04 | 276 | 68 | 11 | HP:0007513 |
| HumanPheno | Albinism | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 MTOR PAH HERC2 | 9.34e-04 | 276 | 68 | 11 | HP:0001022 |
| HumanPheno | Hypopigmentation of the skin | ERCC5 SASH1 RREB1 FANCM JMJD1C FANCA BRCA1 BRCA2 MTOR PAH HERC2 | 9.34e-04 | 276 | 68 | 11 | HP:0001010 |
| HumanPheno | Abnormality of habitus | 9.78e-04 | 87 | 68 | 6 | HP:0010718 | |
| HumanPheno | Abnormality of the outer ear | ERCC5 MAN2B1 NUP107 FOXP2 SMCHD1 PCLO PHF6 BBS2 IREB2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 HECW2 ACAN ASXL3 BUB1 PAH KMT2A CC2D2A NHS MACF1 HERC1 TOPORS TBCD | 1.01e-03 | 1337 | 68 | 30 | HP:0000356 |
| HumanPheno | Almond-shaped palpebral fissure | 1.05e-03 | 59 | 68 | 5 | HP:0007874 | |
| HumanPheno | Abnormal nasal bridge morphology | DMXL2 ERCC5 MAN2B1 PDGFRB PCLO BBS2 RREB1 TRRAP JMJD1C SHANK3 BRCA1 MTOR HECW2 ACAN ASXL3 RLIM PAH KMT2A CC2D2A NHS MACF1 HERC2 HERC1 TOPORS MED13 | 1.08e-03 | 1029 | 68 | 25 | HP:0000422 |
| HumanPheno | Irregular hyperpigmentation | 1.09e-03 | 238 | 68 | 10 | HP:0007400 | |
| HumanPheno | Abnormality of the testis size | 1.09e-03 | 238 | 68 | 10 | HP:0045058 | |
| HumanPheno | Short palpebral fissure | 1.10e-03 | 122 | 68 | 7 | HP:0012745 | |
| HumanPheno | Slanting of the palpebral fissure | DMXL2 PDGFRB BBS2 CNKSR2 RREB1 FANCM TRRAP JMJD1C FANCA TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A HERC2 HERC1 TBCD | 1.12e-03 | 739 | 68 | 20 | HP:0200006 |
| HumanPheno | Azoospermia | SPATA7 DMXL2 ERCC5 MAN2B1 SMCHD1 PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C FANCA SEMA3A TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A CC2D2A CHD6 HERC2 TOPORS TBCD | 1.16e-03 | 1157 | 68 | 27 | HP:0000027 |
| HumanPheno | Malar flattening | MAN2B1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 1.16e-03 | 240 | 68 | 10 | HP:0000272 |
| HumanPheno | Abnormality of the tubular bones | DMXL2 MAN2B1 PDGFRB FANCM LARS2 FANCA TGFBR1 ZNF469 BRCA1 BRCA2 ACAN ASXL3 RLIM CC2D2A NHS HERC2 HERC1 TBCD | 1.18e-03 | 632 | 68 | 18 | HP:0100713 |
| HumanPheno | Abnormality of the long tubular bones | DMXL2 MAN2B1 PDGFRB FANCM LARS2 FANCA TGFBR1 ZNF469 BRCA1 BRCA2 ACAN ASXL3 RLIM CC2D2A NHS HERC2 HERC1 TBCD | 1.18e-03 | 632 | 68 | 18 | HP:0100714 |
| HumanPheno | Abnormal preputium morphology | 1.24e-03 | 36 | 68 | 4 | HP:0100587 | |
| HumanPheno | Patent ductus arteriosus | FOXP2 AGGF1 RREB1 FANCM LARS2 TRRAP JMJD1C SHANK3 FANCA TGFBR1 BRCA1 BRCA2 KMT2A | 1.36e-03 | 382 | 68 | 13 | HP:0001643 |
| HumanPheno | Preaxial polydactyly | 1.39e-03 | 164 | 68 | 8 | HP:0100258 | |
| HumanPheno | Hernia | DMXL2 MAN2B1 NUP107 SMCHD1 RREB1 FANCM TRRAP JMJD1C FANCA TGFBR1 ZNF469 BRCA1 BRCA2 MTOR BUB1 RLIM CC2D2A | 1.45e-03 | 589 | 68 | 17 | HP:0100790 |
| HumanPheno | Functional abnormality of the bladder | NRIP1 MAN2B1 FOXP2 PDGFRB BBS2 RREB1 FANCM TRRAP JMJD1C SHANK3 FANCA BRCA1 BRCA2 ATXN1 MACF1 MMP1 TBCD | 1.48e-03 | 590 | 68 | 17 | HP:0000009 |
| HumanPheno | Multiple cafe-au-lait spots | 1.51e-03 | 64 | 68 | 5 | HP:0007565 | |
| HumanPheno | Abnormal malar bone morphology | MAN2B1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 1.54e-03 | 249 | 68 | 10 | HP:0012369 |
| HumanPheno | Polydactyly | NUP107 BBS2 RREB1 FANCM JMJD1C FANCA TGFBR1 BRCA1 BRCA2 PAH CC2D2A TOPORS | 1.56e-03 | 340 | 68 | 12 | HP:0010442 |
| HumanPheno | Abnormal external genitalia | SPATA7 DMXL2 ERCC5 MAN2B1 NUP107 SMCHD1 PHF6 BBS2 MECOM RREB1 FANCM TRRAP JMJD1C FANCA SEMA3A TGFBR1 BRCA1 BRCA2 MTOR ASXL3 BUB1 RLIM KMT2A CC2D2A CHD6 MMP1 HERC2 HERC1 TOPORS TBCD | 1.58e-03 | 1372 | 68 | 30 | HP:0000811 |
| HumanPheno | Abnormal zygomatic arch morphology | MAN2B1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 1.59e-03 | 250 | 68 | 10 | HP:0005557 |
| HumanPheno | Abnormal zygomatic bone morphology | MAN2B1 RREB1 JMJD1C SHANK3 TGFBR1 ACAN ASXL3 RLIM CHD6 HERC1 | 1.59e-03 | 250 | 68 | 10 | HP:0010668 |
| HumanPheno | Abnormal midface morphology | MAN2B1 FOXP2 PDGFRB SMCHD1 COBLL1 PCLO IREB2 RREB1 JMJD1C SHANK3 TGFBR1 MTOR HECW2 ACAN ASXL3 RLIM CC2D2A CHD6 HERC1 | 1.60e-03 | 704 | 68 | 19 | HP:0000309 |
| HumanPheno | Long toe | 1.62e-03 | 168 | 68 | 8 | HP:0010511 | |
| MousePheno | abnormal trophoblast giant cell morphology | 1.64e-05 | 106 | 148 | 8 | MP:0005033 | |
| MousePheno | abnormal mural trophectoderm morphology | 1.76e-05 | 107 | 148 | 8 | MP:0012057 | |
| Domain | PDZ | SHANK1 PCLO ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 1.37e-07 | 151 | 170 | 11 | PS50106 |
| Domain | PDZ | SHANK1 PCLO ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 1.47e-07 | 152 | 170 | 11 | IPR001478 |
| Domain | PDZ | SHANK1 ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 6.63e-07 | 141 | 170 | 10 | PF00595 |
| Domain | PDZ | SHANK1 ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 1.04e-06 | 148 | 170 | 10 | SM00228 |
| Domain | - | SHANK1 ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 1.17e-06 | 150 | 170 | 10 | 2.30.42.10 |
| Domain | SH3_2 | 1.34e-05 | 86 | 170 | 7 | PF07653 | |
| Domain | SH3_2 | 1.34e-05 | 86 | 170 | 7 | IPR011511 | |
| Domain | ZF_CCHHC | 2.52e-05 | 7 | 170 | 3 | PS51802 | |
| Domain | SAM | 1.52e-04 | 88 | 170 | 6 | SM00454 | |
| Domain | SH3 | 1.66e-04 | 216 | 170 | 9 | PS50002 | |
| Domain | SH3_domain | 1.90e-04 | 220 | 170 | 9 | IPR001452 | |
| Domain | SAM_DOMAIN | 2.32e-04 | 95 | 170 | 6 | PS50105 | |
| Domain | SAM | 2.60e-04 | 97 | 170 | 6 | IPR001660 | |
| Domain | - | 3.80e-04 | 16 | 170 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 3.80e-04 | 16 | 170 | 3 | SM00146 | |
| Domain | SAM_1 | 3.86e-04 | 68 | 170 | 5 | PF00536 | |
| Domain | - | 4.19e-04 | 106 | 170 | 6 | 1.10.150.50 | |
| Domain | Kinase-like_dom | PDGFRB STK32B OBSCN MAST2 TRRAP HIPK3 TGFBR1 TTBK2 MYLK3 PIK3C2G MTOR BUB1 MACF1 AKT2 | 4.51e-04 | 542 | 170 | 14 | IPR011009 |
| Domain | FERM_f0 | 4.88e-04 | 4 | 170 | 2 | PF16511 | |
| Domain | FERM_f0 | 4.88e-04 | 4 | 170 | 2 | IPR032425 | |
| Domain | PI3_PI4_kinase | 5.47e-04 | 18 | 170 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 5.47e-04 | 18 | 170 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 5.47e-04 | 18 | 170 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 5.47e-04 | 18 | 170 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 5.47e-04 | 18 | 170 | 3 | PS50290 | |
| Domain | SAM/pointed | 7.08e-04 | 117 | 170 | 6 | IPR013761 | |
| Domain | SH3 | 8.30e-04 | 216 | 170 | 8 | SM00326 | |
| Domain | GPCR_3 | 8.73e-04 | 21 | 170 | 3 | IPR000337 | |
| Domain | 7tm_3 | 1.00e-03 | 22 | 170 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.00e-03 | 22 | 170 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.00e-03 | 22 | 170 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.00e-03 | 22 | 170 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.00e-03 | 22 | 170 | 3 | PS50259 | |
| Domain | GPCR_3_C | 1.00e-03 | 22 | 170 | 3 | IPR017978 | |
| Domain | PH | 1.03e-03 | 278 | 170 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 1.06e-03 | 279 | 170 | 9 | PS50003 | |
| Domain | PH_domain | 1.09e-03 | 280 | 170 | 9 | IPR001849 | |
| Domain | Znf_C2HC | 1.21e-03 | 6 | 170 | 2 | IPR002515 | |
| Domain | zf-C2HC | 1.21e-03 | 6 | 170 | 2 | PF01530 | |
| Domain | FAT | 1.21e-03 | 6 | 170 | 2 | PS51189 | |
| Domain | FATC | 1.21e-03 | 6 | 170 | 2 | PS51190 | |
| Domain | FAT | 1.21e-03 | 6 | 170 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 1.21e-03 | 6 | 170 | 2 | IPR003151 | |
| Domain | FATC_dom | 1.21e-03 | 6 | 170 | 2 | IPR003152 | |
| Domain | PIK_FAT | 1.21e-03 | 6 | 170 | 2 | IPR014009 | |
| Domain | FATC | 1.21e-03 | 6 | 170 | 2 | SM01343 | |
| Domain | PH | 1.21e-03 | 229 | 170 | 8 | PF00169 | |
| Domain | APC_su10/DOC_dom | 1.68e-03 | 7 | 170 | 2 | IPR004939 | |
| Domain | DOC | 1.68e-03 | 7 | 170 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.68e-03 | 7 | 170 | 2 | PF03256 | |
| Domain | APC10 | 1.68e-03 | 7 | 170 | 2 | SM01337 | |
| Domain | IG | ILDR2 IGFN1 PDGFRB TRB OBSCN BCAN FCRLA IGDCC4 SEMA3A NEO1 MYBPC3 | 1.68e-03 | 421 | 170 | 11 | SM00409 |
| Domain | Ig_sub | ILDR2 IGFN1 PDGFRB TRB OBSCN BCAN FCRLA IGDCC4 SEMA3A NEO1 MYBPC3 | 1.68e-03 | 421 | 170 | 11 | IPR003599 |
| Domain | HECT | 1.85e-03 | 27 | 170 | 3 | PF00632 | |
| Domain | HECTc | 1.85e-03 | 27 | 170 | 3 | SM00119 | |
| Domain | HECT_dom | 1.85e-03 | 27 | 170 | 3 | IPR000569 | |
| Domain | HECT | 1.85e-03 | 27 | 170 | 3 | PS50237 | |
| Domain | PH_dom-like | MYO10 ITSN1 OBSCN ARHGEF12 CNKSR2 PTPN4 TBC1D1 OSBPL11 AKAP13 AKT2 SNTA1 | 1.85e-03 | 426 | 170 | 11 | IPR011993 |
| Domain | GPCR_3_mtglu_rcpt | 2.22e-03 | 8 | 170 | 2 | IPR000162 | |
| Domain | DH_1 | 2.60e-03 | 63 | 170 | 4 | PS00741 | |
| Domain | - | MYO10 ITSN1 OBSCN ARHGEF12 CNKSR2 PTPN4 TBC1D1 OSBPL11 AKAP13 AKT2 | 3.16e-03 | 391 | 170 | 10 | 2.30.29.30 |
| Domain | RhoGEF | 3.43e-03 | 68 | 170 | 4 | SM00325 | |
| Domain | - | 3.51e-03 | 333 | 170 | 9 | 2.130.10.10 | |
| Domain | WD40_repeat | 3.52e-03 | 272 | 170 | 8 | IPR001680 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.65e-03 | 335 | 170 | 9 | IPR015943 | |
| Domain | fn3 | 3.70e-03 | 162 | 170 | 6 | PF00041 | |
| Domain | RhoGEF | 3.81e-03 | 70 | 170 | 4 | PF00621 | |
| Domain | DH_2 | 3.81e-03 | 70 | 170 | 4 | PS50010 | |
| Domain | - | 4.01e-03 | 71 | 170 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 4.01e-03 | 71 | 170 | 4 | IPR000219 | |
| Domain | WD_REPEATS_1 | 4.01e-03 | 278 | 170 | 8 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.10e-03 | 279 | 170 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.10e-03 | 279 | 170 | 8 | PS50294 | |
| Domain | MATH | 5.12e-03 | 12 | 170 | 2 | PS50144 | |
| Domain | MATH/TRAF_dom | 5.12e-03 | 12 | 170 | 2 | IPR002083 | |
| Domain | MATH | 5.12e-03 | 12 | 170 | 2 | SM00061 | |
| Domain | MATH | 5.12e-03 | 12 | 170 | 2 | PF00917 | |
| Domain | GDS_CDC24_CS | 5.32e-03 | 39 | 170 | 3 | IPR001331 | |
| Domain | IG_LIKE | ILDR2 IGFN1 PDGFRB TRB OBSCN BCAN FCRLA IGDCC4 SEMA3A NEO1 MYBPC3 | 5.41e-03 | 491 | 170 | 11 | PS50835 |
| Domain | S_TKc | 5.71e-03 | 359 | 170 | 9 | SM00220 | |
| Domain | WD40_repeat_dom | 5.94e-03 | 297 | 170 | 8 | IPR017986 | |
| Domain | NCD3G | 6.01e-03 | 13 | 170 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 6.01e-03 | 13 | 170 | 2 | IPR011500 | |
| Domain | PROTEIN_KINASE_ST | 6.02e-03 | 362 | 170 | 9 | PS00108 | |
| Domain | Ig-like_dom | ILDR2 IGFN1 PDGFRB TRB OBSCN BCAN FCRLA IGDCC4 SEMA3A NEO1 MYBPC3 | 6.45e-03 | 503 | 170 | 11 | IPR007110 |
| Domain | - | 6.98e-03 | 14 | 170 | 2 | 2.60.210.10 | |
| Domain | GPCR_3_CS | 6.98e-03 | 14 | 170 | 2 | IPR017979 | |
| Domain | C2 | 6.98e-03 | 131 | 170 | 5 | PF00168 | |
| Domain | FN3 | 7.01e-03 | 185 | 170 | 6 | SM00060 | |
| Domain | PX | 7.46e-03 | 44 | 170 | 3 | SM00312 | |
| Domain | Ig_I-set | 7.95e-03 | 190 | 170 | 6 | IPR013098 | |
| Domain | I-set | 7.95e-03 | 190 | 170 | 6 | PF07679 | |
| Domain | PI3/4_kinase_CS | 8.00e-03 | 15 | 170 | 2 | IPR018936 | |
| Domain | Protein_kinase_ATP_BS | 8.03e-03 | 379 | 170 | 9 | IPR017441 | |
| Domain | Pkinase | 8.29e-03 | 381 | 170 | 9 | PF00069 | |
| Domain | C2 | 8.39e-03 | 137 | 170 | 5 | SM00239 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | ATG4A SHANK1 ATG16L1 SORBS2 PDGFRB RICTOR RB1CC1 GRM4 GRM5 MTOR RPTOR PAH AKT2 | 1.89e-05 | 367 | 123 | 13 | M48346 |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY | 1.93e-05 | 19 | 123 | 4 | M39903 | |
| Pathway | WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY | 3.85e-05 | 44 | 123 | 5 | M39602 | |
| Pathway | WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS | 3.85e-05 | 44 | 123 | 5 | M46452 | |
| Pathway | WP_AUTOPHAGY | 1.27e-04 | 30 | 123 | 4 | M39904 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 1.41e-04 | 174 | 123 | 8 | M48058 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.64e-04 | 32 | 123 | 4 | MM15326 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 1.64e-04 | 32 | 123 | 4 | M39445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 1.74e-04 | 13 | 123 | 3 | M47398 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 2.73e-04 | 15 | 123 | 3 | M48306 | |
| Pathway | WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION | 3.34e-04 | 16 | 123 | 3 | M48107 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1 | 3.34e-04 | 16 | 123 | 3 | M47457 | |
| Pubmed | EPC2 KLF12 HIVEP1 NUP107 FOXP2 SMCHD1 ZNF507 PHF6 MECOM RREB1 TRRAP JMJD1C NKRF KANSL3 CDC37 UBE2O BRCA1 ATXN1 YAP1 SVIL RLIM MKI67 KMT2A CHD6 USP54 RASSF8 HERC2 HERC1 L3MBTL3 CPEB1 | 5.75e-11 | 1429 | 179 | 30 | 35140242 | |
| Pubmed | CASP8AP2 NRIP1 ANKFY1 HIVEP1 NUP107 ZNF507 MECOM ZDBF2 RB1CC1 RREB1 JMJD1C KIF20B BRCA2 BUB1 TNKS1BP1 CHD6 L3MBTL3 | 7.13e-11 | 418 | 179 | 17 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SORBS2 HIVEP1 ERCC5 ZC3H13 ITSN1 ZNF507 RICTOR RREB1 TRRAP KANSL3 SH2D4A YAP1 RPTOR SVIL MKI67 OSBPL11 TJP2 KMT2A TNKS1BP1 TOPORS MED13 WDR44 | 1.04e-10 | 774 | 179 | 22 | 15302935 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DENND4A ANKFY1 HIVEP1 ANK3 ZC3H13 SMCHD1 ARHGEF12 PHF6 PPHLN1 MAST2 JMJD1C ASXL3 TJP2 MACF1 AKAP13 | 7.30e-10 | 361 | 179 | 15 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A SORBS2 HIVEP1 SASH1 COBLL1 RICTOR MAST2 MYLK3 ATXN1 MTOR YAP1 TBC1D1 RPTOR SVIL TJP2 KMT2A NHS MACF1 AKAP13 TNKS1BP1 USP54 RASSF8 | 7.66e-10 | 861 | 179 | 22 | 36931259 |
| Pubmed | NRIP1 DMXL2 DENND4A ZBTB38 ANKFY1 HIVEP1 KTN1 OBSCN PPHLN1 CMYA5 MAST2 JMJD1C TULP3 NEO1 ATXN1 MACF1 MED13 | 1.00e-09 | 497 | 179 | 17 | 23414517 | |
| Pubmed | SHANK1 DMXL2 SORBS2 ANKFY1 ANK3 FOXP2 ITSN1 KTN1 ARHGEF12 CNKSR2 SIPA1 GRM4 GRM5 SHANK3 EPM2AIP1 UBE2O CELSR2 MTOR RPTOR SVIL MACF1 LRRC7 HERC2 | 1.12e-09 | 963 | 179 | 23 | 28671696 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 NRIP1 HIVEP1 NUP107 ITSN1 ZNF507 MECOM ZDBF2 KIF20B KANSL3 BRCA2 YAP1 RPTOR BUB1 MACF1 TNKS1BP1 TOPORS RPAP2 | 1.82e-09 | 588 | 179 | 18 | 38580884 |
| Pubmed | ATMIN SORBS2 ANKFY1 MYO10 ARHGEF12 PHF6 CNKSR2 SNX13 IGDCC4 EPM2AIP1 TBC1D1 MACF1 PPIP5K1 LRRC7 CHD6 | 3.72e-09 | 407 | 179 | 15 | 12693553 | |
| Pubmed | SHANK1 CASP8AP2 HIVEP1 ANK3 COBLL1 ITSN1 KTN1 HIPK3 SH2D4A ATXN1 MACF1 LRPAP1 AKAP13 CHD6 HERC2 WDR44 | 5.47e-09 | 486 | 179 | 16 | 20936779 | |
| Pubmed | EPC2 TRAF2 NUP107 FOXP2 LGR4 MECOM RICTOR SIPA1 RREB1 MAST2 ZZEF1 TRRAP NKRF KAT7 ZNF469 BRCA1 ATXN1 RPTOR MACF1 USP54 TOPORS RPAP2 ZNF646 | 1.75e-08 | 1116 | 179 | 23 | 31753913 | |
| Pubmed | 2.35e-08 | 7 | 179 | 4 | 17141160 | ||
| Pubmed | TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. | 2.35e-08 | 7 | 179 | 4 | 28489822 | |
| Pubmed | SHLD2 KLF12 ERCC5 TMEM248 ANK3 ZC3H13 ITSN1 ZNF507 OBSCN LGR4 RICTOR TGFBR1 KAT7 TTBK2 RLIM GRAMD2B OSBPL11 TJP2 MACF1 MMP1 HERC1 RAB11FIP3 | 4.81e-08 | 1084 | 179 | 22 | 11544199 | |
| Pubmed | ITSN1 KTN1 MECOM PPHLN1 ZDBF2 RREB1 JMJD1C CDC37 NEO1 UBE2O YAP1 TJP2 LRPAP1 AKAP13 AKT2 CHD6 USP54 RPAP2 | 5.34e-08 | 733 | 179 | 18 | 34672954 | |
| Pubmed | WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy. | 5.67e-08 | 40 | 179 | 6 | 29078390 | |
| Pubmed | NUP107 ZC3H13 COBLL1 PPHLN1 KAT7 SH2D4A YAP1 RPTOR MKI67 OSBPL11 TJP2 NHS AKAP13 TNKS1BP1 WDR44 | 6.12e-08 | 503 | 179 | 15 | 16964243 | |
| Pubmed | SHANK1 ILDR2 DMXL2 SORBS2 ANK3 PCLO ITSN1 KTN1 ARHGEF12 CNKSR2 BCAN SIPA1 GRM5 SHANK3 UBE2O HECW2 RPTOR SVIL TJP2 KMT2A MACF1 TNKS1BP1 LRRC7 USP54 SNTA1 | 9.83e-08 | 1431 | 179 | 25 | 37142655 | |
| Pubmed | 1.09e-07 | 153 | 179 | 9 | 10718198 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 23440873 | ||
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 19145465 | ||
| Pubmed | Expression of the mTOR pathway regulators in human pituitary adenomas indicates the clinical course. | 1.34e-07 | 3 | 179 | 3 | 23898069 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 22143799 | ||
| Pubmed | Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility. | 1.34e-07 | 3 | 179 | 3 | 19724909 | |
| Pubmed | mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. | 1.34e-07 | 3 | 179 | 3 | 24958889 | |
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 1.34e-07 | 3 | 179 | 3 | 25385646 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 28813526 | ||
| Pubmed | The FANC/BRCA Pathway Releases Replication Blockades by Eliminating DNA Interstrand Cross-Links. | 1.34e-07 | 3 | 179 | 3 | 32466131 | |
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 1.34e-07 | 3 | 179 | 3 | 20008564 | |
| Pubmed | 1.34e-07 | 3 | 179 | 3 | 18614546 | ||
| Pubmed | Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function. | 1.34e-07 | 3 | 179 | 3 | 23212520 | |
| Pubmed | ANK3 NUP107 ITSN1 JMJD1C UBE2O SVIL MKI67 NHS MACF1 LRRC7 USP54 | 1.36e-07 | 263 | 179 | 11 | 34702444 | |
| Pubmed | FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells. | 1.67e-07 | 25 | 179 | 5 | 28069738 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATMIN NRIP1 SGSM1 ANK3 MYT1 OBSCN PHF6 PPHLN1 PDE10A CCDC57 TRRAP JMJD1C TULP3 HIPK3 KANSL3 PTPN4 ATXN1 TBC1D1 RPTOR MACF1 AKAP13 LRRC7 CHD6 TBCD RPAP2 | 2.07e-07 | 1489 | 179 | 25 | 28611215 |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 2.18e-07 | 11 | 179 | 4 | 20427287 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | CASP8AP2 EPC2 NUP107 ZC3H13 SMCHD1 KTN1 MECOM PPHLN1 RREB1 FANCM TRRAP JMJD1C NKRF FANCA KANSL3 KAT7 BRCA1 YAP1 MKI67 KMT2A WDR89 CHD6 L3MBTL3 | 2.49e-07 | 1294 | 179 | 23 | 30804502 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | SHANK1 DMXL2 SORBS2 ANK3 PCLO CNKSR2 GRM5 SHANK3 MTOR MACF1 LRRC7 | 2.63e-07 | 281 | 179 | 11 | 28706196 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ATMIN MAN2B1 MYO10 OBSCN LARS2 MAST2 ZZEF1 TRRAP FANCA KANSL3 CELSR2 MTOR RPTOR AKAP13 AKT2 TNKS1BP1 HERC2 HERC1 MED13 TBCD RAB11FIP3 | 2.94e-07 | 1105 | 179 | 21 | 35748872 |
| Pubmed | TRAF2 SORBS2 NUP107 KTN1 RB1CC1 SIPA1 EPM2AIP1 CDC37 SVIL TJP2 MACF1 TNKS1BP1 | 4.16e-07 | 360 | 179 | 12 | 33111431 | |
| Pubmed | ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. | 4.68e-07 | 13 | 179 | 4 | 21795849 | |
| Pubmed | HIVEP1 MAN2B1 SASH1 ANK3 SPINT1 ITSN1 ZZEF1 HIPK3 TBC1D1 MACF1 CHD6 HERC2 HERC1 TOPORS TBCD | 4.79e-07 | 591 | 179 | 15 | 15231748 | |
| Pubmed | mTOR disruption causes intestinal epithelial cell defects and intestinal atrophy postinjury in mice. | 5.34e-07 | 4 | 179 | 3 | 26631481 | |
| Pubmed | mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. | 5.34e-07 | 4 | 179 | 3 | 16221682 | |
| Pubmed | Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. | 5.34e-07 | 4 | 179 | 3 | 16603397 | |
| Pubmed | Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. | 5.34e-07 | 4 | 179 | 3 | 21606591 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 17329400 | ||
| Pubmed | Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities. | 5.34e-07 | 4 | 179 | 3 | 19619545 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 22399812 | ||
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 27211906 | ||
| Pubmed | mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. | 5.34e-07 | 4 | 179 | 3 | 16919458 | |
| Pubmed | Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins. | 5.34e-07 | 4 | 179 | 3 | 18504440 | |
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 25887293 | ||
| Pubmed | 5.34e-07 | 4 | 179 | 3 | 31636454 | ||
| Pubmed | Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. | 5.34e-07 | 4 | 179 | 3 | 23429704 | |
| Pubmed | Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. | 5.34e-07 | 4 | 179 | 3 | 19114562 | |
| Pubmed | EPC2 DMXL2 AGGF1 MAST2 SHANK3 KIF20B EPM2AIP1 UBE2O TBC1D1 SVIL RLIM AKAP13 RASSF8 TBCD RPAP2 ZNF646 | 6.37e-07 | 689 | 179 | 16 | 36543142 | |
| Pubmed | 6.52e-07 | 14 | 179 | 4 | 21795692 | ||
| Pubmed | SHANK1 DMXL2 SORBS2 ANK3 CNKSR2 GRM5 SHANK3 UBE2O MACF1 LRRC7 | 7.94e-07 | 251 | 179 | 10 | 27507650 | |
| Pubmed | 8.86e-07 | 15 | 179 | 4 | 19850877 | ||
| Pubmed | 9.73e-07 | 101 | 179 | 7 | 9872452 | ||
| Pubmed | ANK3 SMCHD1 KTN1 TRRAP JMJD1C NKRF UBE2O YAP1 OSBPL11 TJP2 KMT2A TNKS1BP1 WDR44 RPAP2 | 1.11e-06 | 549 | 179 | 14 | 38280479 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TMEM248 IREB2 RICTOR CNKSR2 MUC13 TRRAP SNX13 FANCA YAP1 NDUFAF7 OSBPL11 MACF1 LRPAP1 HERC2 HERC1 TBCD | 1.11e-06 | 719 | 179 | 16 | 35337019 |
| Pubmed | 1.18e-06 | 16 | 179 | 4 | 27760317 | ||
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 36927703 | ||
| Pubmed | Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation. | 1.33e-06 | 5 | 179 | 3 | 19586661 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 19875983 | ||
| Pubmed | HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth. | 1.33e-06 | 5 | 179 | 3 | 27043084 | |
| Pubmed | Regulation of mTORC1 complex assembly and signaling by GRp58/ERp57. | 1.33e-06 | 5 | 179 | 3 | 21321085 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 21339740 | ||
| Pubmed | BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype. | 1.33e-06 | 5 | 179 | 3 | 37549632 | |
| Pubmed | mTORC1 promotes survival through translational control of Mcl-1. | 1.33e-06 | 5 | 179 | 3 | 18664580 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 18776922 | ||
| Pubmed | mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice. | 1.33e-06 | 5 | 179 | 3 | 19185849 | |
| Pubmed | Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. | 1.33e-06 | 5 | 179 | 3 | 23953116 | |
| Pubmed | mTORC2 Assembly Is Regulated by USP9X-Mediated Deubiquitination of RICTOR. | 1.33e-06 | 5 | 179 | 3 | 33378666 | |
| Pubmed | Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. | 1.33e-06 | 5 | 179 | 3 | 19211835 | |
| Pubmed | mTORC2 phosphorylates protein kinase Cζ to regulate its stability and activity. | 1.33e-06 | 5 | 179 | 3 | 24375676 | |
| Pubmed | Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. | 1.33e-06 | 5 | 179 | 3 | 22461615 | |
| Pubmed | 1.33e-06 | 5 | 179 | 3 | 28101526 | ||
| Pubmed | Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. | 1.33e-06 | 5 | 179 | 3 | 16183647 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 1.49e-06 | 38 | 179 | 5 | 38086370 | |
| Pubmed | DENND4A ARHGEF12 ZDBF2 CDC37 UBE2O NHS MACF1 TNKS1BP1 RASSF8 | 1.51e-06 | 209 | 179 | 9 | 36779422 | |
| Pubmed | SHANK1 DMXL2 SORBS2 ANK3 PDK2 PCLO KTN1 RICTOR CNKSR2 ZDBF2 GRM5 SHANK3 NEO1 UBE2O CELSR2 RPTOR TJP2 MACF1 AKT2 LRRC7 | 1.93e-06 | 1139 | 179 | 20 | 36417873 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | TMEM248 INPP1 SMCHD1 GPN1 AGGF1 PPHLN1 RICTOR FANCM NKRF UBE2O BRCA1 MTOR TBC1D1 MKI67 RPAP2 | 2.26e-06 | 670 | 179 | 15 | 22990118 |
| Pubmed | PIH1D1 interacts with mTOR complex 1 and enhances ribosome RNA transcription. | 2.65e-06 | 6 | 179 | 3 | 24036451 | |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 19299511 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 29059166 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 23872070 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 30865892 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 21177249 | ||
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 16962653 | ||
| Pubmed | Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability. | 2.65e-06 | 6 | 179 | 3 | 26833090 | |
| Pubmed | Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis. | 2.65e-06 | 6 | 179 | 3 | 28784627 | |
| Pubmed | 2.65e-06 | 6 | 179 | 3 | 22500797 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | FOXP2 SMCHD1 GPN1 RB1CC1 TULP3 SEMA3A CELSR2 MTOR MKI67 MACF1 RPAP2 | 2.80e-06 | 358 | 179 | 11 | 32460013 |
| Pubmed | Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. | 3.79e-06 | 21 | 179 | 4 | 23637172 | |
| Pubmed | CASP8AP2 SASH1 SMCHD1 ZNF507 ZZEF1 KANSL3 UBE2O HECW2 RPTOR TNKS1BP1 L3MBTL3 MED13 ZNF646 | 4.05e-06 | 529 | 179 | 13 | 14621295 | |
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 33150381 | ||
| Pubmed | Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis. | 4.62e-06 | 7 | 179 | 3 | 30154246 | |
| Pubmed | 4.62e-06 | 7 | 179 | 3 | 19047368 | ||
| Interaction | YWHAZ interactions | ATG16L1 DMXL2 TRAF2 DENND4A SORBS2 HIVEP1 SASH1 NUP107 COBLL1 SH2D3C LGR4 RICTOR CNKSR2 RB1CC1 SIPA1 MAST2 SHANK3 STAC CDC37 PTPN4 BRCA1 ATXN1 MTOR YAP1 TBC1D1 ASXL3 RPTOR SVIL TJP2 KMT2A NHS MACF1 AKAP13 USP54 RASSF8 HERC2 | 6.45e-10 | 1319 | 175 | 36 | int:YWHAZ |
| Interaction | YWHAH interactions | NRIP1 ATG16L1 DENND4A SORBS2 HIVEP1 SASH1 ZC3H13 COBLL1 PPHLN1 RICTOR RB1CC1 SIPA1 MAST2 CDC37 PTPN4 ATXN1 MTOR YAP1 TBC1D1 RPTOR SVIL TJP2 KMT2A CC2D2A NHS MACF1 AKAP13 TNKS1BP1 USP54 RASSF8 HERC1 CPEB1 | 1.53e-09 | 1102 | 175 | 32 | int:YWHAH |
| Interaction | YWHAQ interactions | NRIP1 ATG16L1 DENND4A ZBTB38 SORBS2 SASH1 NUP107 ZC3H13 COBLL1 RICTOR SIPA1 LARS2 MAST2 SHANK3 CDC37 PTPN4 BRCA1 ATXN1 MTOR YAP1 TBC1D1 RPTOR SVIL TJP2 KMT2A NHS MACF1 AKAP13 USP54 RASSF8 TBCD | 8.49e-09 | 1118 | 175 | 31 | int:YWHAQ |
| Interaction | YWHAB interactions | ATG16L1 DENND4A SORBS2 HIVEP1 SASH1 NUP107 COBLL1 RICTOR RB1CC1 SIPA1 MAST2 TRRAP SHANK3 STAC CDC37 PTPN4 ATXN1 MTOR YAP1 TBC1D1 SVIL TJP2 KMT2A NHS MACF1 AKAP13 USP54 RASSF8 | 5.41e-08 | 1014 | 175 | 28 | int:YWHAB |
| Interaction | PHF21A interactions | CASP8AP2 ANKFY1 HIVEP1 NUP107 ZNF507 MECOM ZDBF2 RB1CC1 RREB1 JMJD1C KIF20B BRCA2 BUB1 TNKS1BP1 CHD6 L3MBTL3 | 5.52e-08 | 343 | 175 | 16 | int:PHF21A |
| Interaction | CSNK2A1 interactions | NRIP1 ATG16L1 DENND4A ERCC5 ZC3H13 GPN1 MECOM RICTOR CNKSR2 TRRAP SHANK3 NKRF CDC37 KAT7 TTBK2 PTPN4 UBE2O BRCA1 ATXN1 HECW2 ASXL3 KMT2A MACF1 TNKS1BP1 MMP1 USP54 WDR44 | 6.12e-08 | 956 | 175 | 27 | int:CSNK2A1 |
| Interaction | YWHAG interactions | ATG16L1 DENND4A SORBS2 HIVEP1 SASH1 ZC3H13 COBLL1 SH2D3C LGR4 RICTOR RB1CC1 SIPA1 MAST2 TRRAP SHANK3 CDC37 PTPN4 ATXN1 MTOR YAP1 TBC1D1 RPTOR SVIL TJP2 KMT2A NHS MACF1 PPIP5K1 AKAP13 USP54 RASSF8 | 1.04e-07 | 1248 | 175 | 31 | int:YWHAG |
| Interaction | RCOR1 interactions | CASP8AP2 KLF12 ANKFY1 HIVEP1 NUP107 MYT1 MECOM ZDBF2 RB1CC1 RREB1 JMJD1C KIF20B BRCA2 BUB1 MKI67 TNKS1BP1 CHD6 L3MBTL3 | 3.24e-07 | 494 | 175 | 18 | int:RCOR1 |
| Interaction | NUP43 interactions | ATG4A CASP8AP2 ATG16L1 HIVEP1 ERCC5 NUP107 ZC3H13 PPHLN1 RICTOR ZDBF2 CCDC168 JMJD1C NKRF KANSL3 BRCA1 BRCA2 RLIM MKI67 KMT2A CHD6 | 5.44e-07 | 625 | 175 | 20 | int:NUP43 |
| Interaction | KDM1A interactions | CASP8AP2 NRIP1 ATG16L1 ANKFY1 HIVEP1 NUP107 MYT1 ZNF507 MECOM ZDBF2 RB1CC1 RREB1 TRRAP JMJD1C KIF20B BRCA1 BRCA2 ATXN1 YAP1 BUB1 TNKS1BP1 CHD6 FAM9A RASSF8 L3MBTL3 | 6.22e-07 | 941 | 175 | 25 | int:KDM1A |
| Interaction | SPTBN1 interactions | NRIP1 SASH1 ANK3 ITSN1 RICTOR CNKSR2 TRRAP SHANK3 TGFBR1 BRCA1 YAP1 SVIL TNKS1BP1 LRRC7 HERC2 HSPB2 | 8.72e-07 | 421 | 175 | 16 | int:SPTBN1 |
| Interaction | YWHAE interactions | ATG16L1 DENND4A SORBS2 HIVEP1 SASH1 COBLL1 KTN1 RICTOR RB1CC1 MAST2 SHANK3 STAC CDC37 PTPN4 UBE2O BRCA1 ATXN1 MTOR YAP1 TBC1D1 RPTOR SVIL TJP2 KMT2A NHS MACF1 AKAP13 USP54 RASSF8 | 1.28e-06 | 1256 | 175 | 29 | int:YWHAE |
| Interaction | MED17 interactions | ATG16L1 ZC3H13 GPN1 TRRAP UBE2O BRCA1 YAP1 KMT2A HERC2 MED13 RPAP2 | 1.60e-06 | 202 | 175 | 11 | int:MED17 |
| Interaction | DHX40 interactions | ATG16L1 ERCC5 ZC3H13 KTN1 PPHLN1 ZDBF2 RREB1 NKRF EPM2AIP1 UBE2O BRCA1 HERC1 | 1.92e-06 | 249 | 175 | 12 | int:DHX40 |
| Interaction | RMI2 interactions | 2.15e-06 | 25 | 175 | 5 | int:RMI2 | |
| Interaction | PRSS1 interactions | 3.32e-06 | 73 | 175 | 7 | int:PRSS1 | |
| Interaction | ZZZ3 interactions | 3.56e-06 | 139 | 175 | 9 | int:ZZZ3 | |
| Interaction | DCAF12 interactions | 4.63e-06 | 108 | 175 | 8 | int:DCAF12 | |
| Interaction | RPS6KA1 interactions | ARHGEF12 MAST2 GPR162 TRRAP SHANK3 CDC37 KAT7 MTOR RPTOR AKT2 SNTA1 | 5.15e-06 | 228 | 175 | 11 | int:RPS6KA1 |
| Interaction | FANCE interactions | 5.57e-06 | 30 | 175 | 5 | int:FANCE | |
| Interaction | BUB3 interactions | ZBTB38 TRRAP KANSL3 UBE2O BRCA1 ATXN1 YAP1 ASXL3 BUB1 KMT2A HERC2 | 6.08e-06 | 232 | 175 | 11 | int:BUB3 |
| Interaction | SGK1 interactions | 6.15e-06 | 80 | 175 | 7 | int:SGK1 | |
| Interaction | MCRS1 interactions | SASH1 AGGF1 SHANK3 TULP3 KANSL3 KAT7 TTBK2 BRCA1 TBC1D1 KMT2A FAM9A | 6.87e-06 | 235 | 175 | 11 | int:MCRS1 |
| Interaction | NASP interactions | 1.38e-05 | 207 | 175 | 10 | int:NASP | |
| Interaction | LYN interactions | ILDR2 ATG16L1 ANK3 COBLL1 ITSN1 SH2D3C RICTOR TULP3 CDC37 SH2D4A YAP1 SVIL RLIM OSBPL11 KMT2A MACF1 AKT2 TNKS1BP1 RASSF8 | 1.70e-05 | 720 | 175 | 19 | int:LYN |
| Interaction | MED14 interactions | 1.91e-05 | 171 | 175 | 9 | int:MED14 | |
| Interaction | MED15 interactions | 1.92e-05 | 131 | 175 | 8 | int:MED15 | |
| Interaction | TRAF2 interactions | CASP8AP2 NRIP1 TRAF2 MYO10 SH2D3C RB1CC1 MAST2 CDC37 UBE2O SH2D4A ATXN1 MTOR YAP1 FAM9A USP54 HSPB2 ZNF646 | 2.11e-05 | 603 | 175 | 17 | int:TRAF2 |
| Interaction | RMI1 interactions | 2.11e-05 | 39 | 175 | 5 | int:RMI1 | |
| Interaction | CNKSR2 interactions | 2.32e-05 | 66 | 175 | 6 | int:CNKSR2 | |
| Interaction | PPP1CC interactions | ATG16L1 SORBS2 ZC3H13 PPHLN1 ZDBF2 TRRAP SHANK3 NKRF UBE2O SH2D4A BRCA1 ATXN1 YAP1 SVIL RLIM MKI67 AKAP13 RASSF8 RPAP2 | 2.39e-05 | 738 | 175 | 19 | int:PPP1CC |
| Interaction | KCTD13 interactions | SHANK1 ILDR2 LAMB4 DMXL2 SORBS2 ANK3 PCLO ITSN1 KTN1 ARHGEF12 CNKSR2 BCAN SIPA1 GRM5 SHANK3 CDC37 KAT7 UBE2O HECW2 RPTOR SVIL TJP2 KMT2A MACF1 TNKS1BP1 LRRC7 USP54 SNTA1 | 2.69e-05 | 1394 | 175 | 28 | int:KCTD13 |
| Interaction | EZR interactions | ATG16L1 ANK3 NUP107 COBLL1 ITSN1 SH2D3C ARHGEF12 RICTOR SH2D4A BRCA1 YAP1 SVIL RLIM MACF1 TNKS1BP1 WDR44 | 2.73e-05 | 553 | 175 | 16 | int:EZR |
| Interaction | HSD17B7P2 interactions | 2.93e-05 | 21 | 175 | 4 | int:HSD17B7P2 | |
| Interaction | ZYX interactions | ITSN1 HIPK3 ATXN1 YAP1 SVIL BUB1 OSBPL11 TJP2 MACF1 AKAP13 TNKS1BP1 RASSF8 | 3.20e-05 | 329 | 175 | 12 | int:ZYX |
| Interaction | OCLN interactions | ILDR2 ANKFY1 ANK3 COBLL1 ITSN1 ARHGEF12 RICTOR TULP3 TGFBR1 TJP2 NHS MACF1 TNKS1BP1 USP54 RASSF8 | 3.24e-05 | 500 | 175 | 15 | int:OCLN |
| Interaction | HDAC1 interactions | CASP8AP2 NRIP1 ATG16L1 ANKFY1 HIVEP1 NUP107 MYT1 ZNF507 PHF6 MECOM ZDBF2 RB1CC1 RREB1 JMJD1C KIF20B BRCA1 BRCA2 ATXN1 YAP1 BUB1 MKI67 KMT2A TNKS1BP1 L3MBTL3 | 3.31e-05 | 1108 | 175 | 24 | int:HDAC1 |
| Interaction | TNRC6A interactions | ATG16L1 RB1CC1 FANCM UBE2O BRCA1 RLIM TJP2 TNKS1BP1 USP54 MED13 CPEB1 | 3.51e-05 | 280 | 175 | 11 | int:TNRC6A |
| Interaction | ZNF148 interactions | 3.80e-05 | 144 | 175 | 8 | int:ZNF148 | |
| Interaction | C2CD4B interactions | 3.85e-05 | 44 | 175 | 5 | int:C2CD4B | |
| Interaction | SUMO1 interactions | CASP8AP2 TRAF2 NUP107 HIPK3 BRCA1 ATXN1 MTOR YAP1 MKI67 TJP2 TOPORS | 4.39e-05 | 287 | 175 | 11 | int:SUMO1 |
| Interaction | YY1 interactions | KLF12 HIVEP1 FOXP2 SMCHD1 MECOM TRRAP KANSL3 BRCA1 MTOR RPTOR MKI67 KMT2A LRPAP1 L3MBTL3 | 4.45e-05 | 454 | 175 | 14 | int:YY1 |
| Interaction | CALM3 interactions | DENND4A PDGFRB MYO10 KTN1 ARHGEF12 GRM5 MYLK3 YAP1 TBC1D1 HECW2 SVIL RLIM | 4.79e-05 | 343 | 175 | 12 | int:CALM3 |
| Interaction | TCOF1 interactions | ZBTB38 GPN1 OBSCN LGR4 ZZEF1 TRRAP BRCA1 ATXN1 YAP1 MKI67 RASSF8 | 5.13e-05 | 292 | 175 | 11 | int:TCOF1 |
| Interaction | KLF12 interactions | 5.14e-05 | 194 | 175 | 9 | int:KLF12 | |
| Interaction | HCFC1 interactions | ATG16L1 ZBTB38 MECOM KANSL3 UBE2O BRCA1 ATXN1 YAP1 ASXL3 MKI67 KMT2A | 5.29e-05 | 293 | 175 | 11 | int:HCFC1 |
| Interaction | HSP90B1 interactions | ATG16L1 DMXL2 MYO10 RICTOR RB1CC1 TRRAP KIF20B FANCA CDC37 UBE2O BRCA1 BRCA2 YAP1 MKI67 KMT2A AKAP13 HERC2 | 5.39e-05 | 650 | 175 | 17 | int:HSP90B1 |
| Interaction | MMP8 interactions | 6.03e-05 | 25 | 175 | 4 | int:MMP8 | |
| Interaction | TTN interactions | ATG16L1 KTN1 OBSCN MECOM MAST2 TULP3 NEO1 BRCA1 KMT2A HSPB2 MYBPC3 | 6.35e-05 | 299 | 175 | 11 | int:TTN |
| Interaction | ASF1A interactions | CASP8AP2 ATG16L1 HIVEP1 ZC3H13 RREB1 KIF20B BRCA1 BRCA2 KMT2A CHD6 | 6.66e-05 | 249 | 175 | 10 | int:ASF1A |
| Interaction | ELF2 interactions | 6.71e-05 | 156 | 175 | 8 | int:ELF2 | |
| Interaction | GSK3B interactions | TRAF2 DENND4A ARHGEF12 RICTOR ZDBF2 SHANK3 CDC37 UBE2O ATXN1 MTOR YAP1 HECW2 MKI67 NHS MACF1 AKT2 TNKS1BP1 CHD6 RASSF8 HERC2 | 6.85e-05 | 868 | 175 | 20 | int:GSK3B |
| Interaction | ADAMTS13 interactions | 7.07e-05 | 26 | 175 | 4 | int:ADAMTS13 | |
| Interaction | FAAP24 interactions | 7.07e-05 | 26 | 175 | 4 | int:FAAP24 | |
| Interaction | FEV interactions | 7.29e-05 | 203 | 175 | 9 | int:FEV | |
| Interaction | SYNGAP1 interactions | SHANK1 DMXL2 SORBS2 PDGFRB KTN1 CNKSR2 GRM5 SHANK3 MTOR AKAP13 LRRC7 | 8.04e-05 | 307 | 175 | 11 | int:SYNGAP1 |
| Interaction | GNB1 interactions | ATG16L1 RICTOR CNKSR2 SHANK3 UBE2O MTOR YAP1 RPTOR SVIL RLIM AKT2 | 8.04e-05 | 307 | 175 | 11 | int:GNB1 |
| Interaction | BRCA1 interactions | NRIP1 HIVEP1 ERCC5 NUP107 INPP1 SMCHD1 GPN1 OBSCN PPHLN1 RICTOR FANCM KIF20B NKRF EPM2AIP1 FANCA CDC37 BRCA1 BRCA2 MTOR RPTOR MKI67 HERC2 HERC1 PRPF39 RPAP2 | 8.07e-05 | 1249 | 175 | 25 | int:BRCA1 |
| Interaction | MED8 interactions | 9.08e-05 | 121 | 175 | 7 | int:MED8 | |
| Interaction | HSP90AB1 interactions | ATG16L1 DMXL2 TRAF2 ANK3 NUP107 PDK2 KTN1 GPN1 RICTOR RB1CC1 FANCA CDC37 BRCA1 BRCA2 MTOR YAP1 ASXL3 RPTOR SVIL RLIM KMT2A | 9.32e-05 | 960 | 175 | 21 | int:HSP90AB1 |
| Interaction | AGAP2 interactions | 9.45e-05 | 210 | 175 | 9 | int:AGAP2 | |
| Interaction | TGFB1I1 interactions | 9.55e-05 | 53 | 175 | 5 | int:TGFB1I1 | |
| Interaction | PCLAF interactions | 9.55e-05 | 53 | 175 | 5 | int:PCLAF | |
| Interaction | COIL interactions | CASP8AP2 ATG16L1 HIVEP1 MYO10 AGGF1 PHF6 RREB1 CCDC57 KAT7 ATXN1 YAP1 MKI67 AKT2 CHD6 L3MBTL3 | 9.88e-05 | 552 | 175 | 15 | int:COIL |
| Interaction | USP54 interactions | 1.02e-04 | 212 | 175 | 9 | int:USP54 | |
| Interaction | CAPZA2 interactions | ATG16L1 SORBS2 KTN1 SIPA1 SHANK3 UBE2O ATXN1 ASXL3 SVIL RLIM MACF1 TNKS1BP1 HSPB2 | 1.02e-04 | 430 | 175 | 13 | int:CAPZA2 |
| Interaction | EIF4G1 interactions | TRAF2 LGR4 RICTOR CCDC57 TRRAP CDC37 BRCA1 ATXN1 RPTOR BUB1 MKI67 TNKS1BP1 HERC2 | 1.10e-04 | 433 | 175 | 13 | int:EIF4G1 |
| Interaction | GSC interactions | 1.11e-04 | 87 | 175 | 6 | int:GSC | |
| Interaction | SMG7 interactions | ATG16L1 HIVEP1 ERCC5 MECOM ZDBF2 JMJD1C NKRF UBE2O BRCA1 TJP2 CPEB1 | 1.13e-04 | 319 | 175 | 11 | int:SMG7 |
| Interaction | SFN interactions | DENND4A SORBS2 SASH1 COBLL1 RICTOR MAST2 KAT7 ATXN1 MTOR YAP1 SVIL TJP2 KMT2A NHS MACF1 AKAP13 USP54 | 1.15e-04 | 692 | 175 | 17 | int:SFN |
| Interaction | NHLH1 interactions | 1.18e-04 | 88 | 175 | 6 | int:NHLH1 | |
| Interaction | CDK19 interactions | 1.18e-04 | 88 | 175 | 6 | int:CDK19 | |
| Interaction | DDB1 interactions | SHLD2 ATG16L1 ZBTB38 ZC3H13 COBLL1 GPN1 PHF6 MECOM RICTOR SHANK3 UBE2O BRCA1 MTOR ASXL3 RPTOR RLIM L3MBTL3 | 1.26e-04 | 697 | 175 | 17 | int:DDB1 |
| Interaction | TNIK interactions | SHANK1 TRAF2 SORBS2 ANK3 FOXP2 CNKSR2 GRM5 SHANK3 EPM2AIP1 MACF1 LRRC7 HERC2 | 1.30e-04 | 381 | 175 | 12 | int:TNIK |
| Interaction | CLK1 interactions | DENND4A ANKFY1 HIVEP1 ERCC5 ZC3H13 ARHGEF12 PPHLN1 ASXL3 TJP2 | 1.30e-04 | 219 | 175 | 9 | int:CLK1 |
| Interaction | BRCA2 interactions | SHANK1 SHLD2 ERCC5 FANCM TRRAP GPR179 KAT7 BRCA1 BRCA2 MKI67 KMT2A HERC1 | 1.39e-04 | 384 | 175 | 12 | int:BRCA2 |
| Interaction | ZBBX interactions | 1.44e-04 | 31 | 175 | 4 | int:ZBBX | |
| Interaction | MYOM2 interactions | 1.44e-04 | 31 | 175 | 4 | int:MYOM2 | |
| Interaction | COTL1 interactions | 1.47e-04 | 58 | 175 | 5 | int:COTL1 | |
| Interaction | OTUD7A interactions | 1.47e-04 | 58 | 175 | 5 | int:OTUD7A | |
| Interaction | LRRC7 interactions | 1.47e-04 | 58 | 175 | 5 | int:LRRC7 | |
| Interaction | PRDX2 interactions | ATG16L1 PDGFRB SH2D3C JMJD1C SHANK3 CDC37 UBE2O YAP1 HECW2 ASXL3 AKAP13 | 1.48e-04 | 329 | 175 | 11 | int:PRDX2 |
| Interaction | ARHGAP21 interactions | 1.49e-04 | 223 | 175 | 9 | int:ARHGAP21 | |
| Interaction | PFN1 interactions | ATG16L1 ANKFY1 COBLL1 PCLO ITSN1 KTN1 ARHGEF12 BRCA1 TJP2 MACF1 AKAP13 TNKS1BP1 WDR44 RPAP2 | 1.49e-04 | 509 | 175 | 14 | int:PFN1 |
| Interaction | RUVBL1 interactions | EPC2 ATG16L1 ITSN1 GPN1 MECOM RICTOR TRRAP SHANK3 UBE2O BRCA1 MTOR YAP1 ASXL3 RPTOR KMT2A | 1.55e-04 | 575 | 175 | 15 | int:RUVBL1 |
| Interaction | TEAD1 interactions | 1.55e-04 | 176 | 175 | 8 | int:TEAD1 | |
| Interaction | CCNK interactions | 1.56e-04 | 132 | 175 | 7 | int:CCNK | |
| Interaction | LZTS2 interactions | ATG16L1 TRAF2 IGFN1 ZBTB38 SORBS2 ANK3 SIPA1 SHANK3 STAC SH2D4A BRCA2 YAP1 USP54 RASSF8 | 1.59e-04 | 512 | 175 | 14 | int:LZTS2 |
| Interaction | CENPI interactions | 1.60e-04 | 59 | 175 | 5 | int:CENPI | |
| Interaction | AKT1S1 interactions | 1.63e-04 | 32 | 175 | 4 | int:AKT1S1 | |
| Interaction | NCKAP5 interactions | 1.63e-04 | 32 | 175 | 4 | int:NCKAP5 | |
| Interaction | AFDN interactions | ILDR2 SORBS2 LGR4 RICTOR ATXN1 YAP1 TJP2 KMT2A MACF1 USP54 RASSF8 | 1.64e-04 | 333 | 175 | 11 | int:AFDN |
| Interaction | XRCC6 interactions | ATG16L1 ZBTB38 SMCHD1 MECOM RICTOR CCDC57 TRRAP JMJD1C CDC37 UBE2O BRCA1 BRCA2 YAP1 ASXL3 RPTOR RLIM MKI67 KMT2A SNTA1 TBCD | 1.68e-04 | 928 | 175 | 20 | int:XRCC6 |
| Interaction | EIF4EBP1 interactions | 1.70e-04 | 94 | 175 | 6 | int:EIF4EBP1 | |
| Interaction | RAPGEF5 interactions | 1.73e-04 | 60 | 175 | 5 | int:RAPGEF5 | |
| Interaction | KLF3 interactions | 1.76e-04 | 228 | 175 | 9 | int:KLF3 | |
| Interaction | PRNP interactions | EPC2 DMXL2 INPP1 AGGF1 BCAN PDE10A MAST2 GRM5 SHANK3 KIF20B EPM2AIP1 UBE2O TBC1D1 SVIL RLIM TJP2 MACF1 AKAP13 RASSF8 SNTA1 TBCD RPAP2 ZNF646 | 1.79e-04 | 1158 | 175 | 23 | int:PRNP |
| Interaction | SETD2 interactions | 1.80e-04 | 135 | 175 | 7 | int:SETD2 | |
| Interaction | CWF19L2 interactions | 1.95e-04 | 182 | 175 | 8 | int:CWF19L2 | |
| Interaction | ACTN4 interactions | ATG16L1 SORBS2 ANKFY1 SMCHD1 SH2D3C RICTOR SHANK3 SVIL RLIM MKI67 LRRC7 TBCD | 2.03e-04 | 400 | 175 | 12 | int:ACTN4 |
| Cytoband | 14q21.2 | 6.33e-05 | 20 | 179 | 3 | 14q21.2 | |
| GeneFamily | PDZ domain containing | SHANK1 PCLO ARHGEF12 CNKSR2 SIPA1 MAST2 SHANK3 PTPN4 TJP2 LRRC7 SNTA1 | 7.08e-09 | 152 | 123 | 11 | 1220 |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 9.08e-06 | 20 | 123 | 4 | 548 | |
| GeneFamily | Sterile alpha motif domain containing | 3.01e-05 | 88 | 123 | 6 | 760 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 2.73e-04 | 4 | 123 | 2 | 1332 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.73e-04 | 4 | 123 | 2 | 574 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 4.53e-04 | 5 | 123 | 2 | 1333 | |
| GeneFamily | Fibronectin type III domain containing | 7.93e-04 | 160 | 123 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.19e-04 | 161 | 123 | 6 | 593 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.06e-03 | 66 | 123 | 4 | 722 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.25e-03 | 8 | 123 | 2 | 281 | |
| GeneFamily | Autophagy related | 1.44e-03 | 33 | 123 | 3 | 1022 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.86e-03 | 36 | 123 | 3 | 823 | |
| GeneFamily | WD repeat domain containing | 2.11e-03 | 262 | 123 | 7 | 362 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.87e-03 | 206 | 123 | 6 | 682 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.54e-03 | 18 | 123 | 2 | 91 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 DMXL2 HIVEP1 SASH1 MYO10 SMCHD1 ITSN1 MECOM RB1CC1 LARS2 MAST2 ZZEF1 TRRAP KIF20B SNX13 PTPN4 BRCA1 BRCA2 ATXN1 YAP1 TJP2 MACF1 AKAP13 MED13 | 3.50e-09 | 856 | 176 | 24 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | KLF12 ANK3 COBLL1 LGR4 MECOM PDE10A WDFY2 PTPN4 ATXN1 PIK3C2G SVIL NHS | 1.83e-08 | 208 | 176 | 12 | M39233 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 3.34e-07 | 176 | 176 | 10 | M39223 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 3.88e-07 | 137 | 176 | 9 | M39241 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | KLF12 ARHGEF12 TRRAP JMJD1C ATXN1 TBC1D1 MKI67 TJP2 HERC2 HERC1 | 1.03e-06 | 199 | 176 | 10 | M9124 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 3.02e-06 | 131 | 176 | 8 | M39232 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.77e-06 | 180 | 176 | 9 | M8239 | |
| Coexpression | LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX | 5.22e-06 | 141 | 176 | 8 | M39235 | |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 7.85e-06 | 197 | 176 | 9 | M9569 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 8.52e-06 | 199 | 176 | 9 | M5893 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 8.87e-06 | 200 | 176 | 9 | M387 | |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP | 8.87e-06 | 200 | 176 | 9 | M7358 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | ILDR2 KLF12 DMXL2 SPINT1 STK32B KCTD4 IREB2 CMYA5 ZZEF1 STAC TULP3 SH2D4A BRCA2 SNX7 ACAN WDR89 CHD6 RASSF8 HSPB2 | 1.07e-05 | 899 | 176 | 19 | M2242 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | ZBTB38 SASH1 PDGFRB MYO10 RB1CC1 TGFBR1 ZNF469 ATXN1 YAP1 SVIL RLIM NHS AKAP13 TNKS1BP1 MMP1 RASSF8 | 1.55e-05 | 681 | 176 | 16 | M39175 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | ILDR2 KLF12 DMXL2 SPINT1 STK32B KCTD4 IREB2 CMYA5 ZZEF1 STAC TULP3 SH2D4A BRCA2 SNX7 ACAN WDR89 CHD6 RASSF8 HSPB2 | 1.72e-05 | 930 | 176 | 19 | MM893 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 HIVEP1 MYO10 SMCHD1 ITSN1 LARS2 TRRAP KIF20B SNX13 BRCA1 YAP1 TJP2 MED13 | 1.72e-05 | 466 | 176 | 13 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE | 2.14e-05 | 171 | 176 | 8 | M39234 | |
| Coexpression | GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP | 3.47e-05 | 183 | 176 | 8 | M8832 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 3.75e-05 | 240 | 176 | 9 | M39236 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 NRIP1 ZBTB38 ERCC5 MYO10 SMCHD1 KTN1 AGGF1 RB1CC1 KIF20B SNX13 BRCA1 MKI67 PRPF39 HSPB2 | 3.93e-05 | 656 | 176 | 15 | M18979 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | KLF12 DENND4A SASH1 ANK3 FSIP1 INPP1 COBLL1 RICTOR SNX13 SH2D4A TJP2 LRPAP1 USP54 L3MBTL3 | 4.24e-05 | 583 | 176 | 14 | M17454 |
| Coexpression | MATHEW_FANCONI_ANEMIA_GENES | 4.72e-05 | 11 | 176 | 3 | M12972 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL | HIVEP1 FOXP2 PDGFRB MYT1 OBSCN ZDBF2 CMYA5 TOX2 SNTA1 MYBPC3 RAB11FIP3 | 4.96e-05 | 375 | 176 | 11 | M39162 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SHLD2 DENND4A MYO10 COBLL1 GPN1 AGGF1 JMJD1C SH2D4A ATXN1 YAP1 SNX7 SVIL TJP2 WDR89 NHS PPIP5K1 AKAP13 | 5.72e-05 | 843 | 176 | 17 | M2356 |
| Coexpression | BURTON_ADIPOGENESIS_12 | 6.10e-05 | 32 | 176 | 4 | M1558 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 6.10e-05 | 32 | 176 | 4 | MM668 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN | 6.28e-05 | 199 | 176 | 8 | M3626 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 6.28e-05 | 199 | 176 | 8 | M3641 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_DN | 6.50e-05 | 200 | 176 | 8 | M8261 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 6.50e-05 | 200 | 176 | 8 | M9889 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN | 6.50e-05 | 200 | 176 | 8 | M8651 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ATG4A ILDR2 ZBTB38 HIVEP1 FOXP2 MYO10 ITSN1 RICTOR PDE10A RREB1 SNX13 HIPK3 SH2D4A TBC1D1 HECW2 MACF1 MED13 | 6.71e-05 | 854 | 176 | 17 | M1533 |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | ERCC5 PDGFRB KTN1 ARHGEF12 MECOM FANCA BRCA1 BRCA2 KMT2A AKT2 | 7.02e-05 | 323 | 176 | 10 | M9150 |
| Coexpression | BERNARD_PPAPDC1B_TARGETS_UP | 1.09e-04 | 37 | 176 | 4 | M15315 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | CASP8AP2 NRIP1 NUP107 PDGFRB KIF20B FANCA PTPN4 BRCA1 BUB1 MKI67 | 1.10e-04 | 341 | 176 | 10 | M2879 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.10e-04 | 276 | 176 | 9 | M3063 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | ATG4A COBLL1 PHF6 FANCM KIF20B NKRF SNX13 EPM2AIP1 BRCA1 BRCA2 MKI67 TJP2 MACF1 USP54 RASSF8 HERC2 RPAP2 | 1.14e-04 | 892 | 176 | 17 | M18120 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.30e-04 | 221 | 176 | 8 | M39222 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.51e-04 | 169 | 176 | 7 | M39230 | |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 1.68e-04 | 172 | 176 | 7 | M8234 | |
| Coexpression | MURARO_PANCREAS_ENDOTHELIAL_CELL | SASH1 SH2D3C ARHGEF12 MECOM SHANK3 CDC37 TGFBR1 TBC1D1 MACF1 MMP1 | 1.78e-04 | 362 | 176 | 10 | M39176 |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.81e-04 | 295 | 176 | 9 | M39121 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | ATG16L1 MYO10 ZC3H13 STK32B WDFY2 IGDCC4 UTS2 MMP1 TOX2 L3MBTL3 HSPB2 | 1.91e-04 | 437 | 176 | 11 | M15981 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.46e-04 | 183 | 176 | 7 | M2993 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | ILDR2 ZBTB38 HIVEP1 FOXP2 MYO10 ITSN1 RICTOR PDE10A RREB1 SNX13 HIPK3 SH2D4A TBC1D1 HECW2 MACF1 MED13 | 3.39e-04 | 888 | 176 | 16 | MM1018 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 3.73e-04 | 196 | 176 | 7 | M5381 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 3.73e-04 | 196 | 176 | 7 | M4244 | |
| Coexpression | CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE | 3.76e-04 | 91 | 176 | 5 | M39299 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | NRIP1 SASH1 ANK3 PCLO ITSN1 KTN1 ZDBF2 MUC13 SHANK3 STAC PIK3C2G KMT2A MACF1 PAQR7 | 3.84e-04 | 721 | 176 | 14 | M1999 |
| Coexpression | GSE22886_TH1_VS_TH2_12H_ACT_DN | 3.85e-04 | 197 | 176 | 7 | M4509 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_NKCELL_UP | 3.96e-04 | 198 | 176 | 7 | M5420 | |
| Coexpression | GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN | 4.09e-04 | 199 | 176 | 7 | M3204 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN | 4.09e-04 | 199 | 176 | 7 | M3622 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 4.09e-04 | 199 | 176 | 7 | M6028 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN | 4.09e-04 | 199 | 176 | 7 | M7976 | |
| Coexpression | GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN | 4.21e-04 | 200 | 176 | 7 | M3377 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 4.21e-04 | 200 | 176 | 7 | M301 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 4.21e-04 | 200 | 176 | 7 | M9923 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP | 4.21e-04 | 200 | 176 | 7 | M8488 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 4.21e-04 | 200 | 176 | 7 | M8854 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP | 4.21e-04 | 200 | 176 | 7 | M6357 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 4.21e-04 | 200 | 176 | 7 | M9205 | |
| Coexpression | GSE7852_LN_VS_FAT_TCONV_DN | 4.21e-04 | 200 | 176 | 7 | M5748 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 4.43e-04 | 265 | 176 | 8 | M1684 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KLF12 DENND4A ZBTB38 SMCHD1 KTN1 SH2D3C AGGF1 PPHLN1 RICTOR RB1CC1 SIPA1 JMJD1C TGFBR1 PTPN4 ATXN1 TBC1D1 KMT2A MACF1 AKAP13 HERC1 MED13 TBCD | 4.44e-04 | 1492 | 176 | 22 | M40023 |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 4.45e-04 | 53 | 176 | 4 | M6303 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | MAN2B1 ANK3 SPINT1 MYO10 IGDCC4 KAT7 NEO1 CELSR2 NDUFAF7 ACAN MKI67 TJP2 CPEB1 | 4.72e-04 | 650 | 176 | 13 | MM1042 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | IGFN1 ZBTB38 ANK3 PCLO MYT1 STK32B ARHGEF12 RICTOR RB1CC1 GRM4 GRM5 SHANK3 SEMA3A CBLN4 ASXL3 LRRC7 HERC1 TOX2 | 4.87e-04 | 1106 | 176 | 18 | M39071 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | ILDR2 CASP8AP2 EPC2 KLF12 SORBS2 SGSM1 MYO10 PDK2 PCLO MYT1 KTN1 STK32B MECOM ZDBF2 FANCM LARS2 KIF20B PTPN4 BRCA1 CELSR2 BRCA2 BUB1 TJP2 NHS MACF1 PPIP5K1 TOX2 | 4.00e-08 | 986 | 175 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | ILDR2 PCLO KTN1 ZDBF2 PDE10A FANCM KIF20B NKRF CELSR2 BRCA2 BUB1 TOPORS | 1.33e-07 | 204 | 175 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SPATA7 EPC2 FOXP2 PCLO MYT1 KTN1 ARHGEF12 BBS2 MECOM PPHLN1 LARS2 KIF20B NKRF GPR179 EPM2AIP1 FANCA TGFBR1 BRCA2 NDUFAF7 TBC1D1 MKI67 TJP2 MACF1 CFAP74 TOX2 | 5.99e-07 | 989 | 175 | 25 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | ILDR2 CASP8AP2 SORBS2 MYO10 PCLO MYT1 KTN1 MECOM ZDBF2 LARS2 KIF20B NKRF BRCA1 CELSR2 BRCA2 ATXN1 TOX2 | 7.35e-07 | 493 | 175 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SHANK1 CASP8AP2 EPC2 KLF12 SGSM1 MYO10 ZC3H13 KTN1 PHF6 PPHLN1 ZDBF2 FANCM GRM4 LARS2 KIF20B TGFBR1 PTPN4 BRCA1 CELSR2 BRCA2 MTOR RPTOR BUB1 MKI67 PDP2 NHS AKT2 TOX2 SNTA1 CPEB1 | 8.31e-07 | 1370 | 175 | 30 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | ILDR2 CASP8AP2 EPC2 MYO10 PCLO KTN1 ZDBF2 LARS2 PTPN4 BRCA1 CELSR2 BUB1 NHS | 1.22e-06 | 298 | 175 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | SHANK1 ILDR2 SORBS2 PCLO KTN1 MECOM LARS2 PTPN4 CELSR2 ATXN1 TOX2 | 1.42e-06 | 210 | 175 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | ILDR2 CASP8AP2 SORBS2 MYO10 PCLO MYT1 KTN1 MECOM ZDBF2 PDE10A FANCM LARS2 KIF20B NKRF FANCA PTPN4 BRCA1 CELSR2 BRCA2 ATXN1 NHS CHD6 PRPF39 TOX2 | 1.89e-06 | 983 | 175 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | KLF12 ANK3 FOXP2 MYO10 LGR4 SNX13 HIPK3 TGFBR1 PTPN4 RASSF8 HERC2 PRPF39 L3MBTL3 MED13 | 2.43e-06 | 369 | 175 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | SPATA7 PCLO ARHGEF12 BBS2 KIF20B BRCA1 BRCA2 MKI67 MACF1 TOPORS | 4.54e-06 | 192 | 175 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ILDR2 CASP8AP2 PCLO KTN1 ZDBF2 PDE10A FANCM KIF20B NKRF PTPN4 BRCA1 BRCA2 BUB1 TOPORS PRPF39 WDR44 | 8.99e-06 | 532 | 175 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 ILDR2 EPC2 SMCHD1 PCLO ZNF507 ARHGEF12 BBS2 PPHLN1 ZDBF2 LARS2 UBE2O CELSR2 NDUFAF7 MKI67 MACF1 CFAP74 | 9.13e-06 | 595 | 175 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | KLF12 ANK3 FOXP2 PDGFRB MYO10 HIPK3 SEMA3A TGFBR1 PRPF39 MED13 ZNF646 RAB11FIP3 | 1.14e-05 | 312 | 175 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.39e-05 | 173 | 175 | 9 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | SPATA7 PCLO ARHGEF12 BBS2 LARS2 KIF20B EPM2AIP1 FANCA TGFBR1 BRCA1 BRCA2 ASXL3 MKI67 MACF1 TOPORS | 1.48e-05 | 492 | 175 | 15 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | SHANK1 ILDR2 CASP8AP2 EPC2 KLF12 DENND4A SORBS2 SGSM1 MYO10 PCLO MYT1 KTN1 MECOM ZDBF2 LARS2 PTPN4 BRCA1 ATXN1 PPIP5K1 CHD6 TOX2 | 1.55e-05 | 893 | 175 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | ILDR2 NRIP1 SORBS2 ANK3 SPINT1 PCLO MYT1 MECOM LARS2 CELSR2 TBC1D1 TJP2 WDR89 MACF1 TOX2 | 1.59e-05 | 495 | 175 | 15 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | ILDR2 CASP8AP2 SORBS2 MYO10 PCLO MYT1 KTN1 ZDBF2 LARS2 KIF20B BRCA1 CELSR2 BRCA2 CFAP74 TOX2 | 1.70e-05 | 498 | 175 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | KLF12 ANK3 FOXP2 PDGFRB MYO10 HIPK3 TGFBR1 ASXL3 RPTOR HERC2 PRPF39 MED13 ZNF646 | 1.95e-05 | 385 | 175 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.04e-05 | 139 | 175 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | ILDR2 CASP8AP2 MYO10 KTN1 ZDBF2 KIF20B NKRF BRCA1 BRCA2 ATXN1 | 2.37e-05 | 232 | 175 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.47e-05 | 186 | 175 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | SPATA7 DMXL2 ZBTB38 ANKFY1 TMEM175 ARHGEF12 BBS2 RB1CC1 MAST2 KIF20B BRCA1 BRCA2 TIPIN MKI67 CC2D2A MACF1 LRPAP1 TOPORS RPAP2 | 2.50e-05 | 780 | 175 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ILDR2 CASP8AP2 DENND4A MYO10 PCLO KTN1 ZDBF2 KIF20B NKRF PTPN4 BRCA1 CELSR2 ATXN1 NHS AKAP13 CHD6 PRPF39 | 3.05e-05 | 654 | 175 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | CASP8AP2 EPC2 ANK3 FOXP2 SMCHD1 PHF6 PPHLN1 CNKSR2 ZDBF2 PDE10A FANCM KIF20B NKRF TGFBR1 BRCA1 BRCA2 ASXL3 TIPIN BUB1 MKI67 NHS MACF1 RASSF8 TOPORS PRPF39 | 3.14e-05 | 1241 | 175 | 25 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 3.36e-05 | 149 | 175 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 3.62e-05 | 75 | 175 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | CASP8AP2 EPC2 ERCC5 FOXP2 MYO10 ZC3H13 SMCHD1 KTN1 PHF6 PPHLN1 ZDBF2 FANCM LARS2 KIF20B NKRF TGFBR1 PTPN4 BRCA1 BRCA2 BUB1 MKI67 MACF1 CFAP74 TOPORS PRPF39 | 3.87e-05 | 1257 | 175 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | SHANK1 ILDR2 SORBS2 MYO10 KTN1 MECOM LARS2 CELSR2 ATXN1 TOX2 | 4.18e-05 | 248 | 175 | 10 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ILDR2 CASP8AP2 DMXL2 ZBTB38 MYO10 PCLO KTN1 TMEM175 ZDBF2 RB1CC1 MAST2 KIF20B NKRF BRCA1 BRCA2 TIPIN MKI67 CC2D2A RAB11FIP3 | 5.88e-05 | 831 | 175 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | SHANK1 CASP8AP2 EPC2 MECOM CNKSR2 ZDBF2 KIF20B GPR179 BRCA2 ASXL3 MKI67 NHS MACF1 PRPF39 | 6.06e-05 | 492 | 175 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 6.14e-05 | 209 | 175 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SPATA7 EPC2 KTN1 ZNF507 ARHGEF12 BBS2 PPHLN1 KIF20B NKRF UBE2O BRCA2 ATXN1 NDUFAF7 MKI67 OSBPL11 MACF1 | 6.81e-05 | 629 | 175 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SPATA7 ILDR2 CASP8AP2 SORBS2 MYO10 PCLO MYT1 KTN1 MECOM ZDBF2 PDE10A LARS2 KIF20B NKRF TTBK2 BRCA1 CELSR2 BRCA2 MKI67 CFAP74 TOX2 | 6.82e-05 | 989 | 175 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SPATA7 EPC2 HIVEP1 ZC3H13 SMCHD1 PHF6 BBS2 PPHLN1 FANCM JMJD1C UBE2O MKI67 OSBPL11 MACF1 CFAP74 | 7.06e-05 | 564 | 175 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.11e-04 | 279 | 175 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | ILDR2 SORBS2 MYO10 PCLO KTN1 AGGF1 ZDBF2 LARS2 PTPN4 CELSR2 TOX2 WDR44 | 1.12e-04 | 395 | 175 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | NRIP1 KLF12 SORBS2 ANKFY1 ZC3H13 COBLL1 JMJD1C EPM2AIP1 KAT7 RASSF8 | 1.18e-04 | 281 | 175 | 10 | gudmap_developingGonad_e18.5_epididymis_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.54e-04 | 185 | 175 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | DENND4A PDK2 INPP1 MECOM CNKSR2 FANCM KIF20B IGDCC4 FANCA BRCA2 ATXN1 SVIL BUB1 NHS MACF1 | 1.58e-04 | 607 | 175 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | CASP8AP2 EPC2 ERCC5 FOXP2 MYO10 ZC3H13 SMCHD1 KTN1 PHF6 PPHLN1 ZDBF2 FANCM LARS2 KIF20B NKRF TGFBR1 PTPN4 BRCA1 BRCA2 BUB1 MKI67 MACF1 CFAP74 TOPORS PRPF39 CPEB1 | 1.62e-04 | 1459 | 175 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | SPATA7 ILDR2 EPC2 SORBS2 PCLO MYT1 ARHGEF12 BBS2 PPHLN1 ZDBF2 LARS2 EPM2AIP1 TGFBR1 CELSR2 YAP1 NDUFAF7 TBC1D1 MACF1 CFAP74 TOX2 | 1.72e-04 | 979 | 175 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | CASP8AP2 EPC2 ANK3 FOXP2 SMCHD1 PHF6 PPHLN1 CNKSR2 ZDBF2 PDE10A FANCM GRM4 KIF20B NKRF TGFBR1 BRCA1 BRCA2 ASXL3 TIPIN BUB1 MKI67 NHS MACF1 RASSF8 TOPORS PRPF39 | 1.79e-04 | 1468 | 175 | 26 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SPATA7 CASP8AP2 EPC2 FOXP2 ZC3H13 PHF6 PPHLN1 ZDBF2 PDE10A FANCM LARS2 KIF20B TGFBR1 BRCA1 CELSR2 BRCA2 BUB1 MKI67 MACF1 CFAP74 HERC1 | 1.79e-04 | 1060 | 175 | 21 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | SHANK1 ILDR2 NRIP1 SORBS2 ANK3 SPINT1 PCLO MYT1 LGR4 MECOM LARS2 FANCA CELSR2 ATXN1 TBC1D1 TJP2 WDR89 NHS MACF1 TOX2 | 1.84e-04 | 984 | 175 | 20 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 2.04e-04 | 145 | 175 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | DMXL2 ZBTB38 ITSN1 ARHGEF12 MECOM MUC13 SHANK3 BRCA2 BUB1 MKI67 CC2D2A USP54 | 2.07e-04 | 422 | 175 | 12 | GSM399442_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 2.11e-04 | 246 | 175 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3 | |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | KLF12 DMXL2 ZBTB38 SASH1 PDGFRB COBLL1 ITSN1 ARHGEF12 MECOM MUC13 SHANK3 USP54 | 2.11e-04 | 423 | 175 | 12 | GSM399454_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.12e-04 | 146 | 175 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.13e-04 | 194 | 175 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ILDR2 NRIP1 DMXL2 ANKFY1 ZC3H13 RICTOR RB1CC1 PDE10A JMJD1C EPM2AIP1 BRCA1 BRCA2 BUB1 RLIM HERC1 WDR44 CPEB1 | 2.42e-04 | 776 | 175 | 17 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | ILDR2 SORBS2 MYO10 PCLO MYT1 KTN1 MECOM ZDBF2 LARS2 PTPN4 CELSR2 PPIP5K1 TOX2 | 2.49e-04 | 496 | 175 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.72e-04 | 152 | 175 | 7 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.89e-04 | 203 | 175 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | ILDR2 NRIP1 ANKFY1 ZC3H13 ITSN1 PDE10A JMJD1C EPM2AIP1 RLIM HERC1 | 3.61e-04 | 323 | 175 | 10 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | ILDR2 NRIP1 DMXL2 ANKFY1 PNLIPRP2 ZC3H13 SMCHD1 RICTOR PDE10A JMJD1C EPM2AIP1 CBLN4 ASXL3 RLIM HERC1 TOPORS CPEB1 | 3.65e-04 | 804 | 175 | 17 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | SHANK1 ILDR2 KLF12 DENND4A SORBS2 MYO10 PCLO MYT1 KTN1 MECOM LARS2 CELSR2 ATXN1 PPIP5K1 CHD6 TOX2 | 3.80e-04 | 732 | 175 | 16 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ILDR2 CASP8AP2 MYO10 PCLO KTN1 ZDBF2 PTPN4 BRCA1 CELSR2 ATXN1 | 4.08e-04 | 328 | 175 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | KLF12 FOXP2 SNX13 HIPK3 TGFBR1 ASXL3 RASSF8 HERC2 PRPF39 MED13 | 4.28e-04 | 330 | 175 | 10 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.29e-04 | 271 | 175 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3 | 4.42e-04 | 118 | 175 | 6 | Facebase_RNAseq_e8.5_Floor Plate_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | KLF12 FOXP2 MYO10 HIPK3 TGFBR1 RPTOR RASSF8 HERC2 PRPF39 L3MBTL3 MED13 | 4.72e-04 | 397 | 175 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.77e-04 | 275 | 175 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | SPATA7 SGSM1 PCLO ARHGEF12 BBS2 LARS2 KIF20B EPM2AIP1 FANCA TGFBR1 BRCA1 BRCA2 ASXL3 MKI67 MACF1 LRPAP1 CFAP74 TOPORS RAB11FIP3 | 5.12e-04 | 985 | 175 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | SHANK1 ILDR2 KLF12 DENND4A SORBS2 PCLO MYT1 KTN1 MECOM LARS2 PTPN4 CELSR2 ATXN1 PPIP5K1 TOX2 | 5.52e-04 | 683 | 175 | 15 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.73e-04 | 225 | 175 | 8 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | HIVEP1 PNLIPRP2 MYO10 INPP1 LGR4 RREB1 MAST2 TRRAP IGDCC4 SEMA3A PTPN4 CBLN4 NEO1 SH2D4A HECW2 RLIM AKT2 | 5.75e-04 | 837 | 175 | 17 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4 | 5.75e-04 | 124 | 175 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.92e-04 | 173 | 175 | 7 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_1000_k1 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | KLF12 DMXL2 ITSN1 ARHGEF12 MECOM MUC13 SHANK3 BRCA2 MKI67 CC2D2A USP54 | 6.05e-04 | 409 | 175 | 11 | GSM476663_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ILDR2 KLF12 SORBS2 PDGFRB VGLL2 EPM2AIP1 SEMA3A TGFBR1 ASXL3 PAH AKAP13 RASSF8 PRPF39 L3MBTL3 MED13 SPINK5 | 6.47e-04 | 769 | 175 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_100 | 6.64e-04 | 5 | 175 | 2 | gudmap_kidney_P3_CapMes_Crym_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 7.09e-04 | 129 | 175 | 6 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.15e-04 | 291 | 175 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.20e-04 | 233 | 175 | 8 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | EPC2 HIVEP1 PNLIPRP2 FOXP2 PDGFRB LGR4 ZDBF2 SEMA3A PTPN4 CBLN4 NEO1 SH2D4A HECW2 ASXL3 RLIM AKT2 TOPORS | 7.57e-04 | 858 | 175 | 17 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#4_top-relative-expression-ranked_200 | 8.24e-04 | 51 | 175 | 4 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_200_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | ILDR2 SORBS2 SPINT1 COBLL1 PCLO KTN1 STK32B ZDBF2 LARS2 NKRF CELSR2 TOX2 | 8.56e-04 | 495 | 175 | 12 | Facebase_RNAseq_e8.5_Floor Plate_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ILDR2 NRIP1 KLF12 SORBS2 ANKFY1 ZC3H13 PDE10A JMJD1C EPM2AIP1 KAT7 ATXN1 ASXL3 RLIM RASSF8 HERC1 TOPORS | 8.61e-04 | 790 | 175 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.43e-04 | 91 | 175 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPATA7 EPC2 FOXP2 BBS2 PPHLN1 KIF20B NKRF FANCA BRCA2 MKI67 MACF1 | 9.46e-04 | 432 | 175 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | ILDR2 NRIP1 KLF12 SORBS2 ANKFY1 ZC3H13 COBLL1 JMJD1C EPM2AIP1 KAT7 ATXN1 ASXL3 RLIM RASSF8 HERC1 TOPORS | 9.70e-04 | 799 | 175 | 16 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 9.90e-04 | 92 | 175 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NRIP1 ANKFY1 PNLIPRP2 MYO10 ZC3H13 RREB1 EPM2AIP1 KAT7 CBLN4 BRCA1 ASXL3 RLIM HERC1 TOPORS TOX2 CPEB1 | 1.06e-03 | 806 | 175 | 16 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.09e-03 | 192 | 175 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.10e-03 | 249 | 175 | 8 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | KLF12 FOXP2 MYO10 EPM2AIP1 HIPK3 SEMA3A TGFBR1 ZNF469 ATXN1 TBC1D1 RPTOR RASSF8 HERC2 PRPF39 L3MBTL3 MED13 | 1.13e-03 | 811 | 175 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.16e-03 | 251 | 175 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | NRIP1 KLF12 ANK3 PNLIPRP2 FOXP2 PDGFRB MYO10 HIPK3 TGFBR1 CBLN4 ASXL3 RPTOR HERC2 PRPF39 MED13 ZNF646 | 1.24e-03 | 818 | 175 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | SPATA7 EPC2 PDK2 COBLL1 PCLO MYT1 KTN1 STK32B PDE10A LARS2 KIF20B GPR179 CELSR2 BRCA2 ASXL3 MKI67 MACF1 CFAP74 | 1.24e-03 | 979 | 175 | 18 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.26e-03 | 97 | 175 | 5 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.26e-03 | 97 | 175 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SPATA7 DENND4A PDK2 MECOM CNKSR2 KIF20B IGDCC4 FANCA BRCA2 ATXN1 ASXL3 SVIL MKI67 MACF1 AKAP13 | 1.31e-03 | 744 | 175 | 15 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 1.31e-03 | 98 | 175 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | SPATA7 CASP8AP2 EPC2 FOXP2 ZC3H13 PHF6 PPHLN1 ZDBF2 PDE10A FANCM GRM4 LARS2 KIF20B TGFBR1 BRCA1 CELSR2 BRCA2 BUB1 MKI67 MACF1 CFAP74 HERC1 TOX2 | 1.38e-03 | 1414 | 175 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.42e-03 | 259 | 175 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | DENND4A PDK2 MECOM CNKSR2 KIF20B IGDCC4 FANCA BRCA2 ATXN1 ASXL3 SVIL MKI67 NHS MACF1 AKAP13 PRPF39 | 1.51e-03 | 834 | 175 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | DENND4A FOXP2 VGLL2 PHF6 RREB1 EPM2AIP1 SEMA3A TTBK2 CBLN4 NEO1 PIK3C2G HECW2 RASSF8 L3MBTL3 MED13 WDR44 | 1.55e-03 | 836 | 175 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | SPATA7 ILDR2 SPINT1 COBLL1 LGR4 GRM4 MEP1A TGFBR1 PAH LRPAP1 SERPINF2 PRPF39 MED13 CPEB1 RAB11FIP3 | 1.57e-03 | 758 | 175 | 15 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | DENND4A SMCHD1 RICTOR RB1CC1 JMJD1C ZNF10 KMT2A MACF1 HERC1 MED13 | 4.99e-09 | 188 | 179 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | SORBS2 ANK3 OBSCN ARHGEF12 CMYA5 MAST2 SVIL AKAP13 USP54 MYBPC3 | 5.25e-09 | 189 | 179 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | SORBS2 ANK3 OBSCN ARHGEF12 CMYA5 MAST2 SVIL AKAP13 USP54 MYBPC3 | 5.53e-09 | 190 | 179 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | SORBS2 COBLL1 LGR4 SH2D4A YAP1 RPTOR PAH CHD6 SERPINF2 MED13 | 6.42e-09 | 193 | 179 | 10 | 503a979328c68b096680b71359a26f02fafdff35 |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | ILDR2 CASP8AP2 SGSM1 FCRLA TULP3 MYLK3 BRCA2 PRPF39 RAB11FIP3 | 2.53e-08 | 166 | 179 | 9 | f4698fd08965936d51695d571bd10fb77330d916 |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | ILDR2 CASP8AP2 SGSM1 FCRLA TULP3 MYLK3 BRCA2 PRPF39 RAB11FIP3 | 3.43e-08 | 172 | 179 | 9 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.19e-08 | 176 | 179 | 9 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 7.38e-08 | 188 | 179 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-08 | 192 | 179 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.23e-08 | 193 | 179 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.36e-07 | 156 | 179 | 8 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 180 | 179 | 8 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 180 | 179 | 8 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.00e-07 | 180 | 179 | 8 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 7.30e-07 | 181 | 179 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.61e-07 | 185 | 179 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.33e-07 | 187 | 179 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.05e-06 | 190 | 179 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.05e-06 | 190 | 179 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.09e-06 | 191 | 179 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.09e-06 | 191 | 179 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.14e-06 | 192 | 179 | 8 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.14e-06 | 192 | 179 | 8 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-06 | 193 | 179 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 194 | 179 | 8 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-06 | 195 | 179 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 195 | 179 | 8 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-06 | 195 | 179 | 8 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-06 | 197 | 179 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.54e-06 | 200 | 179 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-06 | 141 | 179 | 7 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.61e-06 | 164 | 179 | 7 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 4.80e-06 | 165 | 179 | 7 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 6.07e-06 | 171 | 179 | 7 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.55e-06 | 173 | 179 | 7 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-06 | 174 | 179 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.80e-06 | 174 | 179 | 7 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-06 | 175 | 179 | 7 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 180 | 179 | 7 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.49e-06 | 180 | 179 | 7 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.80e-06 | 181 | 179 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 9.12e-06 | 182 | 179 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.12e-06 | 182 | 179 | 7 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 9.80e-06 | 184 | 179 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.80e-06 | 184 | 179 | 7 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.01e-05 | 122 | 179 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-05 | 185 | 179 | 7 | f1263899a2d41d182022dc4ca62cbae08a463c89 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.05e-05 | 186 | 179 | 7 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 186 | 179 | 7 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 187 | 179 | 7 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 187 | 179 | 7 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 187 | 179 | 7 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 187 | 179 | 7 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 187 | 179 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 187 | 179 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 188 | 179 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 189 | 179 | 7 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.17e-05 | 189 | 179 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.17e-05 | 189 | 179 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 189 | 179 | 7 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 189 | 179 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 189 | 179 | 7 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 189 | 179 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 190 | 179 | 7 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 190 | 179 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 190 | 179 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.21e-05 | 190 | 179 | 7 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 190 | 179 | 7 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-05 | 191 | 179 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-05 | 191 | 179 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-05 | 191 | 179 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.29e-05 | 192 | 179 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.29e-05 | 192 | 179 | 7 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 192 | 179 | 7 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.29e-05 | 192 | 179 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 179 | 7 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 179 | 7 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 179 | 7 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 193 | 179 | 7 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 193 | 179 | 7 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Hippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 194 | 179 | 7 | 8aeb347b3024354c9505f4f0fddf0b843489dc6b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 179 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-05 | 194 | 179 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.38e-05 | 194 | 179 | 7 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.38e-05 | 194 | 179 | 7 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 195 | 179 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.43e-05 | 195 | 179 | 7 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 195 | 179 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 1.43e-05 | 195 | 179 | 7 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.43e-05 | 195 | 179 | 7 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-05 | 195 | 179 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 195 | 179 | 7 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.48e-05 | 196 | 179 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 196 | 179 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 196 | 179 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-05 | 196 | 179 | 7 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.48e-05 | 196 | 179 | 7 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 197 | 179 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-05 | 197 | 179 | 7 | 9fcfbfbe78e8fe90c76eb37a58ed9dc8ece652a1 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | NRIP1 HIVEP1 MYO10 COBLL1 ITSN1 MECOM JMJD1C KIF20B ATXN1 SVIL AKAP13 | 1.16e-07 | 174 | 176 | 11 | 7530_DN |
| Drug | Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | ATG16L1 MYO10 PDK2 INPP1 AGGF1 MAST2 ZNF10 KMT2A AKT2 SPINK5 | 2.36e-06 | 190 | 176 | 10 | 4362_DN |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.27e-06 | 197 | 176 | 10 | 5456_UP | |
| Drug | fullerene C60 | CASP8AP2 ATG16L1 ZBTB38 HIVEP1 ERCC5 TPD52L3 PDGFRB MYO10 VGLL2 ITSN1 SH2D3C ARHGEF12 PDE10A MAST2 GPR162 SHANK3 KIF20B NKRF KANSL3 TTBK2 UBE2O HECW2 AKT2 SERPINF2 SNTA1 MED13 CPEB1 MYBPC3 | 1.22e-05 | 1498 | 176 | 28 | ctd:C069837 |
| Drug | A-443654 | 1.52e-05 | 20 | 176 | 4 | CID010172943 | |
| Drug | Dasatinib | PDGFRB FANCM KIF20B FANCA SEMA3A NEO1 BRCA1 BRCA2 MTOR ACAN TIPIN BUB1 MKI67 MMP1 | 2.23e-05 | 478 | 176 | 14 | ctd:D000069439 |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; HL60; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2541_UP | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; HL60; HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2022_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 3364_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; HL60; HT_HG-U133A | 2.37e-05 | 197 | 176 | 9 | 2465_UP | |
| Disease | Malignant neoplasm of breast | NRIP1 KTN1 OBSCN MECOM PPHLN1 RB1CC1 PKDREJ FSCB SEMA3A BRCA1 BRCA2 MTOR YAP1 MKI67 OSBPL11 NHS MACF1 AKT2 LRRC7 MMP1 USP54 HERC2 L3MBTL3 ZNF646 | 1.80e-08 | 1074 | 172 | 24 | C0006142 |
| Disease | red blood cell density measurement | SHLD2 KLF12 DENND4A HIVEP1 TPD52L3 COBLL1 ITSN1 MECOM RICTOR PDE10A RREB1 MAST2 JMJD1C KIF20B TJP2 CC2D2A AKAP13 L3MBTL3 | 4.28e-06 | 880 | 172 | 18 | EFO_0007978 |
| Disease | Schizophrenia | SHANK1 NRIP1 KLF12 ANK3 FOXP2 PDGFRB RB1CC1 CMYA5 GRM4 LARS2 GRM5 TRRAP SHANK3 SEMA3A BRCA1 MTOR PAH KMT2A | 4.49e-06 | 883 | 172 | 18 | C0036341 |
| Disease | neuroimaging measurement | SPATA7 ANK3 FOXP2 KTN1 ARHGEF12 CNKSR2 BCAN RREB1 JMJD1C KIF20B SEMA3A CDC37 PTPN4 ZNF469 NEO1 BRCA1 RLIM CC2D2A MACF1 L3MBTL3 | 4.65e-06 | 1069 | 172 | 20 | EFO_0004346 |
| Disease | Fanconi Anemia | 1.28e-05 | 25 | 172 | 4 | C0015625 | |
| Disease | ovarian neoplasm | 1.43e-05 | 134 | 172 | 7 | C0919267 | |
| Disease | Pancytopenia | 1.51e-05 | 26 | 172 | 4 | C0030312 | |
| Disease | Acute monocytic leukemia | 1.51e-05 | 26 | 172 | 4 | C0023465 | |
| Disease | Malignant neoplasm of ovary | 1.65e-05 | 137 | 172 | 7 | C1140680 | |
| Disease | eye measurement | 1.76e-05 | 27 | 172 | 4 | EFO_0004731 | |
| Disease | Fanconi anemia (is_implicated_in) | 2.27e-05 | 10 | 172 | 3 | DOID:13636 (is_implicated_in) | |
| Disease | Miller Dieker syndrome | 2.36e-05 | 29 | 172 | 4 | C0265219 | |
| Disease | mean corpuscular hemoglobin concentration | ATMIN DENND4A COBLL1 ITSN1 IREB2 MECOM RREB1 TULP3 SNX13 IGDCC4 TTBK2 NEO1 ATXN1 HECW2 CC2D2A MACF1 AKAP13 TOX2 MED13 | 2.63e-05 | 1105 | 172 | 19 | EFO_0004528 |
| Disease | cervical cancer (is_implicated_in) | 2.71e-05 | 30 | 172 | 4 | DOID:4362 (is_implicated_in) | |
| Disease | insulin measurement | 2.89e-05 | 267 | 172 | 9 | EFO_0004467 | |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 3.38e-05 | 2 | 172 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 3.38e-05 | 2 | 172 | 2 | C4749652 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.58e-05 | 67 | 172 | 5 | C3463824 | |
| Disease | Benign tumor of pancreas | 5.33e-05 | 13 | 172 | 3 | C0347284 | |
| Disease | skin melanoma (is_implicated_in) | 6.76e-05 | 14 | 172 | 3 | DOID:8923 (is_implicated_in) | |
| Disease | Breast Carcinoma | NRIP1 MECOM RB1CC1 BRCA1 BRCA2 MTOR YAP1 MKI67 AKT2 MMP1 HERC2 L3MBTL3 | 8.08e-05 | 538 | 172 | 12 | C0678222 |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.54e-05 | 41 | 172 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 9.54e-05 | 41 | 172 | 4 | C0858252 | |
| Disease | leiomyoma (implicated_via_orthology) | 1.01e-04 | 3 | 172 | 2 | DOID:127 (implicated_via_orthology) | |
| Disease | neogenin measurement | 1.01e-04 | 3 | 172 | 2 | EFO_0801823 | |
| Disease | Drugs used in diabetes use measurement | 1.33e-04 | 255 | 172 | 8 | EFO_0009924 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.38e-04 | 45 | 172 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Bone marrow hypocellularity | 1.49e-04 | 18 | 172 | 3 | C1855710 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 1.64e-04 | 335 | 172 | 9 | EFO_0009931 | |
| Disease | Pancreatic carcinoma | 1.76e-04 | 19 | 172 | 3 | C0235974 | |
| Disease | Malignant neoplasm of urinary bladder | 1.84e-04 | 141 | 172 | 6 | C0005684 | |
| Disease | Hereditary breast ovarian cancer syndrome | 2.01e-04 | 4 | 172 | 2 | cv:C0677776 | |
| Disease | Adenocarcinoma of prostate | 2.06e-04 | 20 | 172 | 3 | C0007112 | |
| Disease | BREAST CANCER | 2.40e-04 | 21 | 172 | 3 | 114480 | |
| Disease | C-reactive protein measurement | DMXL2 ANK3 COBLL1 RICTOR CCDC168 PDE10A RREB1 GRM5 ZZEF1 FANCA ZNF469 NEO1 CELSR2 TBC1D1 MACF1 TNKS1BP1 L3MBTL3 MYBPC3 | 2.53e-04 | 1206 | 172 | 18 | EFO_0004458 |
| Disease | breast cancer (is_implicated_in) | 2.57e-04 | 150 | 172 | 6 | DOID:1612 (is_implicated_in) | |
| Disease | neutrophil percentage of leukocytes | KLF12 DENND4A ZBTB38 HIVEP1 COBLL1 SH2D3C JMJD1C UBE2O ATXN1 TBC1D1 AKAP13 RPAP2 | 2.58e-04 | 610 | 172 | 12 | EFO_0007990 |
| Disease | Mammary Carcinoma, Human | NRIP1 MECOM RB1CC1 BRCA1 BRCA2 MTOR YAP1 MKI67 AKT2 MMP1 L3MBTL3 | 2.74e-04 | 525 | 172 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NRIP1 MECOM RB1CC1 BRCA1 BRCA2 MTOR YAP1 MKI67 AKT2 MMP1 L3MBTL3 | 2.74e-04 | 525 | 172 | 11 | C1257931 |
| Disease | hair colour measurement | ZBTB38 SASH1 LGR4 GRM5 SNX13 FANCA ZNF469 NEO1 AKAP13 HERC2 L3MBTL3 TBCD | 2.78e-04 | 615 | 172 | 12 | EFO_0007822 |
| Disease | Small cell carcinoma of lung | 2.81e-04 | 54 | 172 | 4 | C0149925 | |
| Disease | Mammary Neoplasms | NRIP1 MECOM RB1CC1 BRCA1 BRCA2 MTOR YAP1 MKI67 AKT2 MMP1 L3MBTL3 | 2.83e-04 | 527 | 172 | 11 | C1458155 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.02e-04 | 364 | 172 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | ovarian cancer (is_implicated_in) | 3.23e-04 | 56 | 172 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | interstitial cystitis (is_marker_for) | 3.34e-04 | 5 | 172 | 2 | DOID:13949 (is_marker_for) | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 3.34e-04 | 5 | 172 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | stem Cell Growth Factor-beta measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0802090 | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 3.34e-04 | 5 | 172 | 2 | EFO_0801690 | |
| Disease | stomach carcinoma (is_marker_for) | 3.60e-04 | 24 | 172 | 3 | DOID:5517 (is_marker_for) | |
| Disease | glucose measurement | ZBTB38 SGSM1 COBLL1 MECOM RREB1 PIK3C2G HERC1 MYBPC3 RAB11FIP3 | 4.13e-04 | 380 | 172 | 9 | EFO_0004468 |
| Disease | glucagon measurement, glucose tolerance test | 4.99e-04 | 6 | 172 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Adult only | 4.99e-04 | 6 | 172 | 2 | C3842001 | |
| Disease | platelet component distribution width | NRIP1 TRAF2 COBLL1 MYT1 MECOM ZZEF1 JMJD1C UBE2O SVIL MACF1 AKAP13 HERC1 RAB11FIP3 | 5.11e-04 | 755 | 172 | 13 | EFO_0007984 |
| Disease | Malignant tumor of breast | 5.14e-04 | 27 | 172 | 3 | cv:C0006142 | |
| Disease | Breast neoplasm | 5.14e-04 | 27 | 172 | 3 | cv:C1458155 | |
| Disease | Familial cancer of breast | 5.14e-04 | 27 | 172 | 3 | cv:C0346153 | |
| Disease | Leukemia, Myelocytic, Acute | 5.50e-04 | 173 | 172 | 6 | C0023467 | |
| Disease | body fat percentage | DMXL2 ZBTB38 HIVEP1 SMCHD1 COBLL1 ZZEF1 FANCA ACAN RPTOR MACF1 | 6.17e-04 | 488 | 172 | 10 | EFO_0007800 |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 6.36e-04 | 29 | 172 | 3 | C0496920 | |
| Disease | schizophrenia (implicated_via_orthology) | 6.79e-04 | 68 | 172 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | refractive error | 6.86e-04 | 326 | 172 | 8 | MONDO_0004892 | |
| Disease | stem cell growth factor-alpha measurement | 6.96e-04 | 7 | 172 | 2 | EFO_0020754 | |
| Disease | degenerative disc disease (implicated_via_orthology) | 6.96e-04 | 7 | 172 | 2 | DOID:90 (implicated_via_orthology) | |
| Disease | Ovarian Carcinoma | 7.04e-04 | 30 | 172 | 3 | C0029925 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 7.32e-04 | 121 | 172 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 7.32e-04 | 121 | 172 | 5 | EFO_0004612, EFO_0005271 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 7.76e-04 | 31 | 172 | 3 | C1335167 | |
| Disease | conduct disorder | 7.76e-04 | 31 | 172 | 3 | EFO_0004216 | |
| Disease | breast cancer (is_marker_for) | 7.81e-04 | 185 | 172 | 6 | DOID:1612 (is_marker_for) | |
| Disease | intraocular pressure measurement | PCLO ARHGEF12 MECOM FANCA ZNF469 MTOR KMT2A AKAP13 HERC2 MYBPC3 | 8.50e-04 | 509 | 172 | 10 | EFO_0004695 |
| Disease | hematocrit | SHLD2 NRIP1 ZBTB38 ANKFY1 HIVEP1 TPD52L3 COBLL1 PHF6 MECOM PDE10A RREB1 MAST2 TTBK2 GRAMD2B L3MBTL3 | 8.91e-04 | 1011 | 172 | 15 | EFO_0004348 |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 9.10e-04 | 127 | 172 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | breast cancer anti-estrogen resistance protein 3 measurement | 9.24e-04 | 8 | 172 | 2 | EFO_0008040 | |
| Disease | Lymphoid leukemia | 9.24e-04 | 8 | 172 | 2 | C0023448 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 9.34e-04 | 74 | 172 | 4 | EFO_0022280 | |
| Disease | Abnormality of radial ray | 9.34e-04 | 33 | 172 | 3 | C4228778 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.46e-04 | 264 | 172 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | Varicose veins | 9.72e-04 | 193 | 172 | 6 | HP_0002619 | |
| Disease | serum gamma-glutamyl transferase measurement | SORBS2 SGSM1 FSIP1 COBLL1 FCRLA RREB1 JMJD1C WDFY2 CELSR2 SVIL KMT2A AKAP13 L3MBTL3 MED13 | 9.78e-04 | 914 | 172 | 14 | EFO_0004532 |
| Disease | hemoglobin A1 measurement | ZBTB38 COBLL1 MYT1 ITSN1 RREB1 MAST2 JMJD1C MACF1 AKAP13 L3MBTL3 | 9.99e-04 | 520 | 172 | 10 | EFO_0007629 |
| Disease | urinary bladder cancer (is_implicated_in) | 1.03e-03 | 76 | 172 | 4 | DOID:11054 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.17e-03 | 200 | 172 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 1.17e-03 | 200 | 172 | 6 | EFO_0000195 | |
| Disease | 22q11 partial monosomy syndrome | 1.18e-03 | 9 | 172 | 2 | C3266101 | |
| Disease | Pancreatic carcinoma, familial | 1.18e-03 | 9 | 172 | 2 | C2931038 | |
| Disease | calcium measurement | ATG16L1 ERCC5 COBLL1 RREB1 KAT7 CELSR2 YAP1 MACF1 SERPINF2 TOX2 L3MBTL3 | 1.20e-03 | 628 | 172 | 11 | EFO_0004838 |
| Disease | Intellectual Disability | 1.30e-03 | 447 | 172 | 9 | C3714756 | |
| Disease | colorectal carcinoma (is_marker_for) | 1.31e-03 | 37 | 172 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | longitudinal BMI measurement | 1.37e-03 | 82 | 172 | 4 | EFO_0005937 | |
| Disease | Bladder Neoplasm | 1.40e-03 | 140 | 172 | 5 | C0005695 | |
| Disease | body surface area | ZBTB38 HIVEP1 SMCHD1 ARHGEF12 RREB1 MTOR ACAN RPTOR MACF1 AKAP13 L3MBTL3 | 1.45e-03 | 643 | 172 | 11 | EFO_0022196 |
| Disease | apolipoprotein A 1 measurement | ZBTB38 COBLL1 BBS2 GRM5 JMJD1C SNX13 CELSR2 KMT2A PDP2 MACF1 TNKS1BP1 HERC1 MYBPC3 | 1.47e-03 | 848 | 172 | 13 | EFO_0004614 |
| Disease | Asymmetric crying face association | 1.47e-03 | 10 | 172 | 2 | C0431406 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.47e-03 | 10 | 172 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | 22q11 Deletion Syndrome | 1.47e-03 | 10 | 172 | 2 | C2936346 | |
| Disease | asthma | DMXL2 ZBTB38 HIVEP1 TPD52L3 FSIP1 VGLL2 MYT1 MECOM GRM4 JMJD1C STAC TGFBR1 | 1.58e-03 | 751 | 172 | 12 | MONDO_0004979 |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 1.59e-03 | 144 | 172 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Semantic-Pragmatic Disorder | 1.79e-03 | 11 | 172 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 1.79e-03 | 11 | 172 | 2 | C0751257 | |
| Disease | Language Delay | 1.79e-03 | 11 | 172 | 2 | C0023012 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TTVIERTFHVDSPDE | 81 | P31751 | |
| SSAISSIARENHEPE | 776 | Q52LR7 | |
| EERTAFHLSDTVPAS | 476 | Q5SNV9 | |
| IFLDPHTTQTFVDTE | 276 | Q8WYN0 | |
| TSHEDLPASQERSEV | 306 | O43683 | |
| DPSLTQRDSFHLDEQ | 246 | P08697 | |
| ETSDHTEETSPVRAI | 246 | Q676U5 | |
| DPSHSVVDFQDQRTL | 721 | Q14833 | |
| EVSSANAEELRHPFS | 1621 | Q12802 | |
| RDDAPASVHSEITDS | 606 | Q8N302 | |
| LRTESIEEHATPNSS | 2301 | Q8TDJ6 | |
| TILVTDTNDHDPVFE | 276 | Q9HCU4 | |
| TEEIHENVISPSDLS | 196 | P30533 | |
| DSSTVERIEDSHSPG | 611 | P54253 | |
| SSTPEEVISAHFSED | 1466 | Q9UKL3 | |
| RPSNSEAHETDTAIS | 561 | Q53SF7 | |
| FSEEAESLTNSHEEP | 476 | Q9C0F0 | |
| LPETATDLSVHSSDE | 1191 | Q9C0F0 | |
| VERIASHDFDPTDSS | 36 | Q9NZN5 | |
| TLADFSLHPESQTVE | 141 | Q8TDY8 | |
| FREESQDTLTHSSPS | 1291 | Q7Z401 | |
| EASHADIEREAPFQS | 371 | Q8NHQ8 | |
| ETFTDEDTSTLVHPE | 321 | O75154 | |
| PTDLTVDHSLQIDFS | 121 | P48200 | |
| LFTNTEPHSITEDVT | 121 | P57740 | |
| LRPQDTDLEATSHFT | 1141 | O75747 | |
| DLESHINETFDIPSS | 486 | P29074 | |
| ESSSSPEIRDQHADD | 621 | Q96JM7 | |
| AELSSFSTSHVPEEL | 1161 | Q03112 | |
| HITVSSDQSVNPFED | 411 | Q9P2R3 | |
| EVTSSVHEDASPEAV | 321 | Q9P2P5 | |
| AHLASISTPEEQDFI | 721 | Q96GW7 | |
| SPDSIDAHTFDFETI | 691 | Q8TDY2 | |
| HQDVAFTDPTLDSTE | 126 | P49441 | |
| VVHRIFVSSDPTTDD | 221 | Q86WK9 | |
| SDRETKNTADHDESP | 111 | O95251 | |
| SASRTDDDVPSLHSE | 1031 | P41594 | |
| SHFTPDEVTVRTVDN | 81 | Q16082 | |
| ARSPLSEETSAEEAH | 491 | Q5H9T9 | |
| RLSHDETNIFSTPRE | 411 | Q16538 | |
| ETTAPADSVSHLDRQ | 1961 | Q6PRD1 | |
| LELEQSTHRHTPETE | 821 | Q96NW7 | |
| DDSEAEQTERNIHPT | 1946 | O95714 | |
| SHVRASQEEDSPDSF | 971 | Q9NQ38 | |
| QVTEDFVSPEHLVES | 2476 | Q15652 | |
| SDDEILEHTSDSNRP | 1241 | Q8IYD8 | |
| QDSADVDPQEHSFTR | 1331 | Q15751 | |
| VDPQEHSFTRTIDEE | 1336 | Q15751 | |
| QEDIVSSSFIIPESH | 2026 | Q9Y6V0 | |
| TRPSLARSDDNDHEV | 426 | Q32MK0 | |
| HPQVLDEFVSESVSA | 26 | Q9Y233 | |
| TTANHSPELEDDREI | 691 | O15409 | |
| DLSHEFSLVAPNTEA | 36 | Q96Q89 | |
| EPNRENSFHSSIEAI | 1046 | Q96Q89 | |
| RTFHLIAESPEDASQ | 1286 | Q9HD67 | |
| TPRETTFLEITDNHD | 136 | Q8WVF5 | |
| HETAEPISDFLSVTE | 1586 | O94854 | |
| TPLRDESTQEHSERA | 731 | P48552 | |
| NLHESDSESVPRDFK | 71 | Q86UP2 | |
| LDANHITSVPEDSFE | 136 | Q9BXB1 | |
| ELFQTPDHTEESTTD | 2081 | P46013 | |
| DSPFAESTFVEDTHE | 961 | Q9H422 | |
| IRTLTEPSVDFNHSD | 1131 | Q6R327 | |
| RVTEESHEEPAFQNF | 346 | Q9HCN4 | |
| EENDVNLTHIESRPS | 56 | P00439 | |
| SEVVVEHPTDFSTEI | 21 | Q86UA1 | |
| KDPEDHRTLSQFTDA | 101 | Q15119 | |
| TQRPAETHLEIESSS | 2226 | P16112 | |
| PEDAEVVARSSHTVT | 4526 | Q5VST9 | |
| TTVLCHDTTRPEEFD | 181 | P51582 | |
| NPFTETREEDVTDEH | 86 | Q8IZU1 | |
| TSTEEDDFHLQLSPE | 66 | Q9P2J9 | |
| EQTSKRHDSDTFPEL | 686 | P38398 | |
| RETQTSGIESPTDDH | 491 | O43313 | |
| HVSASRVFQSPLESD | 51 | Q9BXC9 | |
| RAPTEEVEFSSNQHV | 756 | Q9P2K1 | |
| VRNEEASETVFPHDT | 211 | P51587 | |
| SRTSLSEPEAAEHSF | 2136 | Q8TD26 | |
| EDETHPNIDTASLFR | 16 | Q16543 | |
| PEFQTLLTESESEHG | 316 | Q7L775 | |
| LSSEFQIPTASEDHS | 221 | Q7L513 | |
| TETRESQHASPFLLD | 241 | A0A1W2PPK0 | |
| PEADALSDTERQDFH | 941 | O15360 | |
| IHAPAFISSIDQEES | 2956 | Q8N3K9 | |
| ISFPVSSVESALEHE | 3091 | Q8N3K9 | |
| FESRSHDEITIQPGD | 751 | Q15811 | |
| VAFSAVRSTNHEPSE | 71 | Q9NTU7 | |
| SPDASDQVQSERIHE | 691 | Q8IZF7 | |
| RQHEEEISKDFPSSE | 506 | Q2TAC2 | |
| EQHLTFTREFDSDSL | 946 | Q12955 | |
| TIENEHIRATFDPDT | 606 | O00754 | |
| HFSTESVPDEEGRQS | 276 | Q6P0Q8 | |
| EEEDTFSSVFHTQIP | 191 | Q8NA03 | |
| FVTPRRQHESTIESD | 61 | Q9P2N6 | |
| PEDSLSVDHFQTQTE | 66 | Q9Y4X4 | |
| SVDHFQTQTEPVDLS | 71 | Q9Y4X4 | |
| RTSSSEAHIPDQETT | 3561 | Q03164 | |
| SHTIENVIVSFEPDR | 86 | A4D0S4 | |
| HLPDFQDSEETVTSR | 61 | Q9BZB8 | |
| EAPADSTTFTDAHVE | 696 | Q86VF2 | |
| QDTSPHEDSITSRDI | 1791 | Q8NDH2 | |
| PESENSRDFHATESQ | 276 | Q96HH9 | |
| DPSESQTELSEFVHE | 496 | Q9P1V8 | |
| PESNTTHGIELFEDS | 271 | Q8NEY8 | |
| TQDFTVTFSPDHESL | 1436 | Q9C0B2 | |
| DPSDAVFVDVIHTDS | 211 | P54317 | |
| ELSESHPDSGEQTVR | 421 | P09619 | |
| AVISPSDEDSHTFTV | 111 | Q9BXB4 | |
| RDFSHDDTLDVPTQV | 2511 | P42345 | |
| TDSDPEHRRVSAQLD | 761 | Q9Y5W8 | |
| SREISFQLSAPHEDA | 26 | O95399 | |
| AHFPTLATEVDTSSD | 16 | A0A1B0GWG4 | |
| EAHEEINITFTLPTA | 151 | Q9NWD8 | |
| KPSDSVHITNDDERF | 291 | A6NHR9 | |
| VDTHLFSVESPQELA | 376 | Q13424 | |
| PHIGRSNEEEETSDS | 51 | O95425 | |
| ASQSVILHSPEFEDA | 766 | Q15031 | |
| TAPHANEDASVFVTE | 671 | Q6T4R5 | |
| ATPAEAFIQHDETRD | 256 | Q7L592 | |
| HFVASSSKDERQEDP | 61 | O15226 | |
| VSHSFPATLETQEQD | 16 | P03956 | |
| DTTLDRTFHVTHPDE | 1336 | Q9NTG1 | |
| EHVASTNEGREPTDS | 456 | P28715 | |
| VDFEDITHLSQTEVP | 591 | Q16819 | |
| VTRPHTDTSEVDLFV | 826 | Q92859 | |
| HTGSQELFSSEDELP | 336 | Q86V20 | |
| EERTEFLHSQNSLSP | 826 | Q96FS4 | |
| FISAHLISESDNPED | 226 | Q14563 | |
| QSTDRLLSTEPHEEV | 2041 | Q9UHV7 | |
| HHRTQDDPSFDSLET | 301 | A0A1B0GV85 | |
| DLFITVDEPESHVTT | 31 | Q9UNH6 | |
| DEQPRAHVEFSDSDQ | 586 | O94875 | |
| SPENEEHILSFETID | 771 | Q8N122 | |
| VRHDSATDTIDIAPN | 356 | P36897 | |
| EEVDSRSSSDHPLET | 1676 | Q9Y566 | |
| DSVFSDSAAISPEHR | 791 | Q8WXI2 | |
| EHVIDAFRPDVTSSS | 441 | Q12933 | |
| DLEESFNEHELEPSS | 141 | Q8IWS0 | |
| VSSITRSSEPVQHEE | 946 | Q9UDY2 | |
| THTEISPEQQFDRSV | 56 | Q9BSA9 | |
| ITDEERAPTATFHDS | 351 | Q96P53 | |
| SSVVDEHFSRALSQP | 96 | Q8N8G2 | |
| SVTVSETFDPEEKHS | 221 | Q9H3R2 | |
| GVEEADTRSSSDPHL | 1356 | Q9BYB0 | |
| VEQATAETASPVHRE | 1311 | Q92766 | |
| QDSEEHDSTFPLIDS | 481 | Q8IXW5 | |
| ISELSSLHEEDSNFR | 336 | Q71H61 | |
| SSDHPEDTANVTVTV | 226 | O43278 | |
| ISSQTFEHPLVNETE | 246 | Q9NVW2 | |
| HRTSTSDLVEVPEEA | 226 | Q99469 | |
| DSDAHLFQDSTEPRA | 1601 | Q9C0C2 | |
| TSEISSRDIDPHVEG | 851 | Q6IQ55 | |
| HSVSTETPHERKDFE | 626 | Q86TI0 | |
| ASRDHTDQTSETAPD | 1211 | Q9C0C9 | |
| TAQHLRQSSFEIPDD | 156 | P46937 | |
| QFLTRSEEPEDSVHR | 1481 | O15015 | |
| SVRDEVFHTDQDDPS | 456 | Q5JSH3 | |
| TDSRINFDSHEPLQS | 1281 | Q9HCK1 | |
| EHVFENSPVLDERSA | 291 | O94885 | |
| EEPRKTHSEEFTNSL | 111 | Q9H788 | |
| DENHPSISDSLTDRE | 521 | Q9P0W8 | |
| EHSEPSLSTEDSVLD | 781 | Q2NKQ1 | |
| EVAVFEPSEAEISHT | 146 | P0DTU4 | |
| ATVPHEDTFSAADLT | 1586 | Q96JG9 | |
| QETHPDSETAFEIKS | 81 | P21506 | |
| HIIERFSESRQPDST | 91 | Q9H7R0 | |
| EREQHSLPDTLSIAT | 716 | Q8TCN5 | |
| HSDSSVITISPDEAE | 386 | Q9NS56 | |
| SPSSSTQEEESEVHF | 211 | Q96NM4 | |
| VEEHFQASVSPTEAA | 1466 | O43149 | |
| RQSHLEPDTFEATQD | 41 | Q8N5H7 | |
| DPESRVSSLHDIQSV | 266 | Q9NY57 | |
| VTHTSPEDVSFAESR | 801 | Q9BTW9 | |
| VHFSREDENQSSDVP | 316 | Q8NAP3 | |
| SETHSDDVTQVRFHP | 166 | Q96FK6 | |
| HSTSELEDLTEPEQR | 16 | Q96J77 | |
| NPEREDSETRTHSII | 201 | Q9Y4A5 | |
| DEVHAPSVSSSVVEE | 96 | O75386 | |
| RQPTVHFSDVSSDDD | 2696 | P15822 | |
| EHDVTSTELDPFLTN | 166 | Q9BVW5 | |
| EDNTQDPLSEERFHV | 891 | Q6PFW1 | |
| DVPDRTEVTEAEHTA | 1071 | Q5T200 | |
| LTSVEVDNIEPSAFH | 956 | Q70EL1 | |
| EREEAPVSSHSFDSS | 1426 | Q70EL1 | |
| SEPTHLAVEDVSDTT | 871 | Q14896 | |
| EAAPDVIFQEDTSHT | 306 | Q01538 |